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Helicobacter pylori causes gastrointestinal diseases, including gastric 
cancer.  Mycobacterium tuberculosis induces tuberculosis, claiming the lives 
of millions of people in the world every year. Increasing drug-resistance 
among bacterial pathogens is a serious global health issue. Therefore, 
discovery of new antimicrobial agents is needed urgently. Identifying the 
molecular and biological functions of proteins from pathogenic bacteria 
would provide the groundwork for the development of new antibacterial 
drug targets. In this study, I have determined the crystal structures of Csd6 
from H. pylori and Rv2258c from M. tuberculosis. 
The H. pylori Csd6 protein plays a key role in determining the helical 
cell shape by trimming of peptidoglycan muropeptides. Csd6 is also 
involved in deglycosylation of the flagellar protein FlaA. The structure of 
Csd6 reveals that its middle catalytic domain resembles those of L,D-
transpeptidases but its pocket-shaped active-site shows distinct variations 
from the known L,D-transpeptidases. Mass analyses confirm that Csd6 
functions only as an L,D-carboxypeptidase but not as an L,D-transpeptidase. 
D-Ala-complexed structure of Csd6 reveals binding modes of both the 
 ii 
substrate and product to the catalytic domain. On the basis of structure-
function analysis, Csd6 and its homologs are proposed to constitute a new 
family of L,D-carboxypeptidase. 
The M. tuberculosis Rv2258c protein is predicted to be an S-adenosyl-
L-methionine-dependent methyltransferase (MTase). MTases mediate a wide 
variety of cellular processes, such as cell signaling, metabolite synthesis, and 
gene regulation in nearly all living organisms. The structure of Rv2258c 
shows that its monomer consists of two domains linked by a long α-helix. 
The N-terminal domain is essential for dimerization and the C-terminal 
catalytic domain has the Class I MTase fold. The overall fold of Rv2258c, as 
well as its interactions with bound sinefungin (or S-adenosyl-L-
homocysteine), are similar to small-molecule MTases. Rv2258c has a 
relatively large hydrophobic cavity for binding the methyl-accepting 
substrate, suggesting that bulky nonpolar molecules might be targeted for 
methylation by Rv2258c in M. tuberculosis. 
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The cell-shape determining Csd6 protein from Helicobacter 










Helicobacter pylori is a helical-shaped Gram-negative bacterium that 
colonizes the upper gastroinstestinal tract in approximately half of the 
world’s human population. Its infection of the gastric mucosa is associated 
with various gastric diseases, including chronic gastritis, peptic ulcer, 
mucosa-associated lymphoid tissue lymphoma, and gastric adenocarcinoma 
(Roesler et al., 2014; Kusters et al., 2006). H. pylori is regarded as a primary 
factor for gastric cancer development (Roesler et al., 2014) and was 
classified as a Group I carcinogen by the International Agency for Research 
on Cancer of the World Health Organization. In recent years, H. pylori 
infection has also been implicated with some extra-digestive diseases 
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(Roubaud Baudron et al., 2013). Typical treatment regimens for eradicating 
H. pylori consist of a proton pump inhibitor (for example, omeprazole) and 
the antibiotics such as clarithromycin and amoxicillin (or metronidazole). 
However, increasing drug resistance in H. pylori requires discovery of new 
antibiotics (Malfertheiner et al., 2012). 
High motility of H. pylori is important for its colonization of the human 
stomach and its survival in the viscous gastric mucosa (Ottemann and 
Lowenthal, 2002; Schreiber et al., 2004; Lertsethtakarn et al., 2011). The 
helical cell shape of H. pylori is believed to facilitate penetration of the 
viscous epithelial mucus layer via a cork-screwing mechanism (Berg and 
Turner, 1979; Hazell et al., 1986; Worku et al., 1999) (Figure 1-1). Several 
H. pylori mutants with altered cell shapes exhibited attenuated colonization 
(Wyckoff et al., 2012). The peptidoglycan layer, the major component of the 
bacterial cell wall, plays an essential role in withstanding the turgor pressure 
and in determining the cell shape (Scheffers and Pinho, 2005; Vollmer and 
Bertsche, 2008). It is made of linear polysaccharide chains that consist of 
alternating β-1,4-linked N-acetylglucosamine-N-acetylmuramic acid (NAG-
NAM) disaccharide units, with a pentapeptide linked to NAM (Vollmer et 
al., 2008). In H. pylori, the pentapeptide sequence is L-Ala1-γ-D-Glu2-
mDAP3-D-Ala4-D-Ala5 (or -Gly5), where mDAP refers to meso-2,6-
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diaminopimelate, and the neighboring peptides are cross-linked exclusively 
by the 4→3 linkage between the main-chain of D-Ala4 from one strand and 
the side chain of mDAP3 from another strand (Costa et al., 1999) to form a 
mesh-like structure termed peptidoglycan sacculus (Meroueh et al., 2006; 
Sauvage et al., 2008). Colonization and infection by H. pylori also rely on 
the ability of the bacterium to move toward the part of gastric mucosa with 
more neutral pH. Besides the helical morphology, powerful flagella of H. 
pylori are responsible for its high motility through the viscous gastric mucus 
layer (Ottemann and Lowenthal, 2002; Schreiber et al., 2004; Lertsethtakarn 
et al., 2011). The flagella provide a propulsive torque as well as a rotary 
movement of the cell body; a helical cell shape of H. pylori generates a 
corkscrew-like rotation (Lertsethtakarn et al., 2011; Berg and Turner, 1979; 




Figure 1-1. Strategies of H. pylori for colonization and survival (Bauer 
and Meyer, 2011) 
Using the flagella conferring fast motility, H. pylori cells orientate 
themselves towards the mucosa in close proximity to the epithelial cell layer 
where the pH is near neutral. Its helical cell shape enables a screw-like 
movement to facilitate motility through the viscous mucosal layer. 
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In many bacteria, including H. pylori, the peptidoglycan layer is 
remodeled by a number of cell-wall hydrolases as well as synthetases for the 
peptidoglycan maturation, regulation of cell-wall growth, cell division, 
peptidoglycan turnover and recycling, cell lysis, and the release of 
peptidoglycan fragments for host-pathogen interactions (Vollmer et al., 
2008) (Figure 1-2). In H. pylori, an amidase AmiA (Chaput et al., 2006), 
peptidases Csd1–4, potential regulators Csd5 and CcmA (Sycuro et al., 
2010; Sycuro et al., 2012; Bonis et al., 2010), and another peptidase Csd6 
(Sycuro et al., 2013) are required to tailor the peptidoglycan layer to 
generate the helical cell shape. I have recently reported the crystal structures 
of both Csd4 (HP1075 in strain 26695) (Kim et al., 2014) and Csd3 
(HP0506 in strain 26695) (An et al., 2015). Csd4 is a Zn2+-dependent D,L-
carboxypeptidase (DL-CPase) of the M14 metallopeptidase family and 
cleaves the γ-D-Glu2-mDAP3 bond of the muramyl tripeptide to produce the 
muramyl dipeptide (Sycuro et al., 2012; Kim et al., 2014). Csd3 (also 
known as HdpA) belongs to the M23 metallopeptidase family and has both 
D,D-endopeptidase (DD-EPase) and D,D-carboxypeptidase (DD-CPase) 
activities (Bonis et al., 2010). Csd6 (encoded by the hp0518 gene in H. 
pylori 26695 strain) was identified as another member of the peptidoglycan 
trimming pathway and also a cell-shape determinant of H. pylori (Sycuro et 
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al., 2013). The transposon mutant H. pylori with the disruption of the csd6 
gene or the csd6-deletion mutant displayed a straight rod shape and an 
increase in tetrapeptide-containing muropeptides (Sycuro et al., 2013). 
Incubation of the recombinant hexahistidine-tagged Csd6 with tetrapeptide-
rich sacculi from the Δcsd1csd6 mutant H. pylori resulted in complete 
conversion of the monomeric tetrapeptides to tripeptides (Sycuro et al., 
2013). In Campylobacter jejuni, another helical-shaped gastrointestinal 
pathogen, a homolog of Csd6 has been characterized as an LD-CPase and 
was named as Pgp2 (Frirdich et al., 2014). Loss of pgp2 resulted in the 
morphology defect, changes in the peptidoglycan muropeptide profile, 
reduced motility, and moreover, a decreased interaction with the host 
(Frirdich et al., 2014). Between Csd6 and Pgp2, there exist an overall amino 
acid sequence identity of 36% and similarity of 58%. Given the significance 
of mDAP-containing muramyl tripeptide as an agonist for the cytosolic 
innate immune receptor Nod1 (Girardin et al., 2003; Chamaillard et al., 
2003), an increased amount of muramyl tripeptide as a result of LD-CPase 
reaction by Pgp2 (or Csd6 from H. pylori) was suggested to affect the Nod1 
activation and ultimately the NF-κB transcriptional activity (Frirdich et al., 
2014). The complete absence of tripeptide-containing muropeptides in 
Δpgp2 peptidoglycan did indeed reflect the reduced Nod1 activation, despite 
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Figure 1-2. Schematic illustration of peptidoglycan structure and 
peptidoglycan-modifying hydrolases (modified from Sycuro et al., 2010) 
Peptidoglycan mesh structure is composed of glycan strands (green) 
interconnected by peptide cross-links (purple). Peptide bonds marked with 
orange scissors are hydrolyzed by D,D-endopeptidases (DD-EPases) or D,D-
carboxypeptidases (DD-CPases), those marked with blue scissors are 
hydrolyzed by L,D-carboxypeptidases (LD-CPases), and those marked by 
green scissors are hydrolyzed by D,L-carboxypeptidases (DL-CPases). 
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A bioinformatics analysis on the basis of the amino acid sequence 
predicts that residues 67–200 of H. pylori Csd6 form a YkuD domain 
(formerly called ErfK/YbiS/YcfS/YnhG; ‘L,D-transpeptidase’ catalytic 
domain; Pfam 03734) that can possibly catalyze non-classical 3→3 cross-
linking of peptidoglycan. YkuD domain-containing L,D-transpeptidases (LD-
TPases) have been identified in a range of bacteria, including Enterococcus 
faecium, Bacillus subtilis, and Mycobacterium tuberculosis (Lertsethtakarn 
et al., 2011; Frirdich et al., 2014; Biarrotte-Sorin et al., 2006; Kim et al., 
2013). They generate 3→3 cross-linkages of peptidoglycan, instead of 4→3 
cross-linking catalyzed by classical D,D-transpeptidases, resulting in high-
level resistance to β-lactam antibiotics (Mainardi et al., 2000) or in 
peptidoglycan remodeling for dormancy in M. tuberculosis (Lavollay et al., 
2008). However, the Helicobacter peptidoglycan layer is cross-linked 
exclusively by 4→3 linkages (Costa et al., 1999; Sycuro et al., 2010; Chaput 
et al., 2007). Consistent with the absence of 3→3 cross-linked muropeptides 
in the H. pylori peptidoglycan sacculus, Csd6 was shown to exhibit the LD-
CPase activity only with no “transpeptidase” cross-linking activity against 
the muropeptides (Sycuro et al., 2013). However, it still remains 
unanswered why Csd6 has no “transpeptidase” cross-linking activity despite 
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the presence of a putative ‘LD-TPase’ domain and conservation of the 
catalytic Cys/His residues. 
In many bacterial pathogens, flagella are best known for conferring 
motility and virulence, as well as serving as an export apparatus for 
virulence factors (Young et al., 1999) and sensing the viscosity of a medium 
(McCarter and Silverman, 1990). Flagellar filaments of H. pylori are 
composed of two copolymerized flagellins (FlaA and FlaB) (Kostrzynska et 
al., 1991), which are heavily O-glycosylated with pseudaminic acid 
(Pse5Ac7Ac; Pse), a sialic acid-resembling sugar (Schirm et al., 2003; 
Logan, 2006). The regulation of such post-translational modification is 
critical for the assembly of functional flagella (Schirm et al., 2003; 
Josenhans et al., 2002). Interestingly, a previous work highlighted the 
unique role of H. pylori G27 Csd6 that involves deglycosylation of FlaA; 
the Δcsd6 mutant exhibited altered motility to facilitate host-cell interaction 
and superior colonization (Asakura et al., 2010). It suggests that Csd6 binds 
Pse molecules or deglycosylates O-glycosylated FlaA proteins. 
To better understand the molecular function of H. pylori Csd6, its 
biochemical, biophysical, and structural characterizations have been 
performed in this study. Mass analyses using the synthetic muramyl 
peptides indicate that Csd6 functions only as the L,D-carboxypeptidase (LD-
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CPase) and not as the L,D-transpeptidase (LD-TPase). Analytical 
ultracentrifugation and single-molecule fluorescence resonance energy 
transfer (FRET) analyses indicate that Csd6 exists as a dimer in solution. A 
Csd6 monomer has a three-domain architecture consisting of the N-terminal 
domain (NTD; Val13–Asn56), the middle LD-CPase domain (Lys67–
Glu202), and the C-terminal nuclear transport factor 2-like domain (NTF2-
like domain; Thr209–Lys330). The NTD shows very remote structural 
similarity to other known protein structures and plays a key role in 
dimerization. The middle catalytic domain has an overall fold of the LD-
TPase domain, validating the bioinformatics prediction. However, here this 
catalytic domain is referred to as the ‘LD-CPase’ domain, because I as well 
as others show that Csd6 functions only as an LD-CPase. The Csd6 LD-
CPase domain resembles those of well-characterized LD-TPases but its 
pocket-shaped active-site is uniquely defined by the four loops I–IV, among 
which the loops I and III show the most distinct variations in sequence 
length and conformation from known LD-TPases. The D-Ala-complexed 
structure suggests possible binding modes of both the substrate and product 
to the LD-CPase domain. The NTF2-like domain possesses a deep pocket for 
possible binding of a hydrophobic ligand such as Pse and an in silico 
docking study supports its role in the control of the glycosylation level of 
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flagellin. This work provides further insights into the strategy of H. pylori 
for regulating its helical cell shape and motility, which are crucial for its 
virulence. The reported structural information would serve as the foundation 
in a search for new drug targets to fight infections by H. pylori. 
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1.2. Material and methods 
 
1.2.1. Cloning, expression, and purification 
The csd6 gene (hp0518) from H. pylori 26695 strain encoding the N-
terminally truncated form (residues 13–330) was amplified by the 
polymerase chain reaction (PCR) using the genomic DNA as the template. 
The forward and reverse oligonucleotide used were 5’-G GAA TTC CAT 
ATG GTG GGA TTG AAT GCT AGT GAT CGT-3’ and 5’-CCG CTC 
GAG TTT TTC CAT TAT AAT AGA CAC TTG ATT G-3’, respectively. 
The underlined sequences are NdeI and XhoI restriction enzyme sites, 
respectively. The gene was cloned into the expression vector pET-28b(+) 
(Novagen) to express the recombinant Csd6 protein fused with a His6-
containing tag at its N-terminus. It was overexpressed in Escherichia coli 
Rosetta2(DE3)pLysS cells using a Luria Broth culture medium. Protein 
expression was induced by 0.5 mM isopropyl -D-thiogalactopyranoside 
and the cells were incubated for additional 20 h at 18C following growth to 
mid-log phase at 37C. The cells were lysed by sonication in buffer A (50 
mM Tris-HCl at pH 7.9, 500 mM sodium chloride, and 50 mM imidazole) 
containing 10% (v/v) glycerol and 1 mM phenylmethylsulfonyl fluoride. 
The crude lysate was centrifuged at 36,000 g for 1 h. The recombinant Csd6 
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protein showed a tendency to aggregate at 4C and, therefore, it was 
purified at room temperature in two column chromatography steps. The 
supernatant was applied to an affinity chromatography column of HiTrap 
Chelating HP (GE Healthcare), which was previously equilibrated with 
buffer A. Upon eluting with a gradient of imidazole in the same buffer, the 
Csd6 protein was eluted at 120150 mM imidazole concentration. The 
eluted protein was applied to a HiLoad XK-16 Superdex 200TM column (GE 
Healthcare), which was previously equilibrated with 20 mM Tris-HCl at pH 
7.9 and 150 mM sodium chloride (Figure 1-3A). Fractions containing the 
Csd6 protein were pooled and concentrated to 5.8 mg ml-1 for crystallization 
using an YM10 ultrafiltration membrane (Amicon). This construct gave the 
best crystals in crystallization experiments. Other constructs were also tried 
for expression and crystallization. The Val13–Lys330 construct fused with a 
C-terminal His6-containing tag was not expressed in E. coli 
Rosetta2(DE3)pLysS cells. The constructs covering residues 4–330 or 17–
330 were expressed at very low levels and were insoluble. The construct 
covering residues 1–330 (full-length) was expressed in a soluble form but its 
crystals diffracted poorly to 7 Å only.  
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As a positive control in the LD-TPase assay, LdtMt2, an LD-TPase 
encoded by the rv2518c gene of M. tuberculosis H37Rv strain, was used. 
The N-terminal region (Leu20–Ala42) of LdtMt2 is predicted to form a 
putative transmembrane helix; the gene covering residues Ala55–Ala408, 
fused with a His6-containing tag at its C-terminus, was cloned into pET-
21a(+) (Novagen). The recombinant LdtMt2 was overexpressed and purified 




Figure 1-3. SDS-PAGE analysis and crystals of Csd6 from H. pylori 
(A) SDS-PAGE analysis of Csd6 purified by size exclusion chromatography. 
(B) A crystal of Csd6 with approximate dimensions of 0.2 mm  0.1 mm  
0.05 mm after optimization. 
BA 
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1.2.2. Crystallization and X-ray data collection 
To solve the phase problem by anomalous diffraction, ethyl mercury 
thiosalicylate (EMTS)-derivative crystals of the recombinant Csd6 (residues 
13–330) were obtained at 23C by co-crystallization in the presence of 
EMTS by the sitting-drop vapor diffusion method. Sitting drops were 
prepared by mixing 3 l of the protein solution and 2 l of the reservoir 
solution [250 mM potassium nitrate, 18% (w/v) polyethylene glycol (PEG) 
3,350, and 10 mM EMTS]. EMTS-derivatized crystals grew to approximate 
dimensions of 0.1 mm  0.1 mm  0.05 mm within a few days. They were 
transferred to a cryoprotectant solution, which contained 25% (v/v) glycerol 
in the reservoir solution. Single-wavelength anomalous diffraction (SAD) 
data were collected at 100 K at the BL-4A experimental station of Pohang 
Light Source, Korea. The raw data were processed using the program suite 
HKL2000 (Otwinowski and Minor, 1997). The crystal of EMTS-derivatized 
Csd6 belongs to the space group P212121, with unit cell parameters of a = 
61.8 Å, b = 89.6 Å, c = 128.7 Å, and  =  =  = 90 (Table 1-1). 
Native crystals of ligand-free Csd6 (Csd6-unbound) were grown at 
23C by the sitting-drop vapor diffusion method. Sitting drops were 
prepared by mixing 0.5 l of the protein solution, 0.1 l of a ten-fold diluted 
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microseed crystal solution, and 0.4 l of the reservoir solution [1.5% (v/v) 
Tacsimate at pH 7.0, 22% (w/v) PEG 3,350, and 100 mM sodium-HEPES at 
pH 7.5]. The microseed crystals were originally obtained with Csd6-
unbound using the above reservoir solution. The crystals grew to 
approximate dimensions of 0.2 mm  0.1 mm  0.05 mm within a few days 
(Figure 1-3B). They were transferred to a cryoprotectant solution, which 
contained 20% (v/v) glycerol in the reservoir solution. X-ray diffraction data 
for Csd6-unbound were collected at 100 K at the BL-1A experimental 
station of Photon Factory, Japan. The crystal of Csd6-unbound belongs to 
the space group P212121, with unit cell parameters of a = 62.9 Å, b = 91.0 Å, 
c = 127.7 Å, and  =  =  = 90 (Table 1-1). To collect the D-Ala-bound 
Csd6 (Csd6-Ala) diffraction data, a native crystal was pre-incubated for 2 
min in a cryoprotectant solution containing both 20% (v/v) glycerol and 96 
mM D-Ala, which were added to the reservoir solution. X-ray diffraction 
data for the Csd6-Ala were collected at 100 K at the BL-5C experimental 
station of Pohang Light Source, Korea. The crystal of Csd6-Ala belongs to 
the space group P212121, with unit cell parameters of a = 63.4 Å, b = 90.6 Å, 
c = 127.9 Å, and  =  =  = 90 (Table 1-1). 
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Table 1-1. Statistics for data collection, phasing, and model refinement 
A. Data collection 
Data set EMTS-peak Csd6-unbound Csd6-Ala 
Beamline sourcea PLS BL-4A PF BL-1A PLS BL-5C 
Space group P212121 P212121 P212121 
a, b, c (Å) 61.8, 89.6, 128.7 63.0, 91.0, 127.8 63.4, 90.6, 127.9 
X-ray wavelength (Å) 1.0048 1.0000 0.9796 
Resolution rangeb (Å) 
50.0 – 2.90 
(2.95 – 2.90) 
50.0 – 2.03 
(2.07 – 2.03) 
50.0 – 2.04 
(2.08 – 2.04) 
No. total reflectionsb 373,689 (18,354) 229,193 (11,715) 227,623 (11,074) 
No. unique reflectionsb 30,311 (1,515)c 47,555 (2,343) 47,575 (2,307) 
Completeness (%)b 99.9 (100)c 98.3 (98.1) 99.9 (100) 
<I> / <I>b 35.0 (4.7)c 25.0 (3.0) 29.3 (3.4) 
Wilson B factor (Å2) 53.1 34.2 30.5 
Rmergeb,d (%) 11.0 (73.1)c 9.5 (47.0) 8.6 (53.7) 
B. SAD phasing Figure of merit (before / after density modification)    0.34 / 0.66 
C. Model refinement 
PDB ID code  4XZZ 4Y4V 
Resolution range (Å)  30.0 – 2.03 30.0 – 2.04 
Rwork / Rfreee (%)  19.6 / 24.8 19.2 / 24.4 
No. of non-hydrogen atoms / average B-factor (Å2) 
Total  5,589 / 40.6 5,631 / 37.7 
Protein   5,248 / 40.4 5,249 / 37.3 
Water oxygen   323 / 41.5 334 / 41.4 
Glycerol  18 / 63.4 30 / 58.2 
D-Ala  - / - 18 / 44.6 
R.m.s. deviations from ideal geometry 
Bond lengths (Å) / angles () 0.009 / 1.33 0.009 / 1.33 
R.m.s. Z-scores    
Bond lengths (Å) / angles () 0.46 / 0.61 0.46 / 0.61 
Ramachandran (%)f 
Favored / Outliers  98.6 / 0.0 97.6 / 0.00 
Poor rotamers (%)f  0.00 0.00 
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Footnotes to Table 1-1 
a PF and PLS stand for Photon Factory, Japan and Pohang Light Source, 
Korea, respectively. 
b Values in parentheses refer to the highest resolution shell. 
c Friedel pairs were treated as separate observations. 
d Rmerge = hi  I(h)i – <I(h)>  / hi I(h)i, where I(h) is the intensity of 
reflection h, h is the sum over all reflections, and i is the sum over i 
measurements of reflection h. 
e Rwork =  | |Fobs| – |Fcalc| | /  |Fobs|, where Rfree is calculated for a randomly 
chosen 5% of reflections, which were not used for structure refinement and 
Rwork is calculated for the remaining reflections. 
f Values obtained using MolProbity. 
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1.2.3. Structure determination and refinement 
Two mercury sites in two monomers of EMTS-derivatized Csd6 in the 
crystallographic asymmetric unit were located using the AutoSol program of 
the PHENIX software package (Adams et al., 2010). The initial phases were 
further improved by density modification using the automatic model 
building program Resolve (Terwilliger, 2003). The initial model was 
improved through iterative cycles of model building with Coot (Emsley et 
al., 2010) and refinement with Refmac5 of the CCP4 program suite 
(Murshudov et al., 1997; Winn et al., 2011). The structures of both Csd6-
unbound and Csd6-Ala were determined by molecular replacement with the 
program MolRep (Vagin and Teplyakov, 2010) using the refined model of 
EMTS-derivatized Csd6. Stereochemistry of the refined models was 
evaluated using MolProbity (Chen et al., 2010). Data collection and 
refinement statistics are given in Table 1-1. 
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1.2.4. In silico docking 
Induced Fit Docking (IFD) (Schrödinger Suite Induced Fit Docking 
protocol; Glide version 5.7., Prime version 3.0, Schrödinger, LLC, New 
York, NY, USA) (Yoo et al., 2013; Medina-Franco et al., 2014) was 
employed to predict the binding mode of Pse with consideration of protein 
flexibility. The Csd6 structure (monomer A model) was prepared for 
docking calculations using the Protein Preparation Wizard implemented in 
Maestro (version 9.2, Schrödinger, LLC, New York, NY, USA). The 
structure of Pse was built in Maestro 9.2, and the possible conformations of 
the ligand were generated using LigPrep (version 2.5, Schrödinger, LLC, 
New York, NY, USA). Pse was docked onto Csd6 using the following steps. 
(i) The receptor grid of Csd6 was defined as an enclosing box at the centroid 
of the key amino acid residues (i.e., Trp227, Lys258, Tyr297, Lys313, and 
Glu329) in the binding pocket. (ii) In the initial Glide docking stage, a 
soften potential docking with van der Waals radii scaling of 0.5 for the 
protein and ligand was performed retaining a maximum number of 20 poses 
per ligand. (iii) Residues within 5.0 Å of ligand poses were kept free to 
move in the Prime refinement step, and the side chains were further 
optimized. (iv) Poses within 30 kcal mol-1 of the energy cutoff in the 
previous step were re-docked using Glide XP. (v) The binding energy 
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(IFDScore) for each output pose was computed as implemented in the IFD 
protocol. The best docked poses were also reproduced by a different 
docking program, Surflex-Dock of Sybyl X 2.0 (Tripos Int., St. Louis, MO, 
USA). All the computations were undertaken on an Intel® XeonTM Quad-
core 2.5 GHz workstation with Linux Cent OS release 5.5. 
As a positive control of the docking method, IFD of sialic acid (N-
acetylneuraminic acid; Neu5Ac) and Pse onto Micromonospora 
viridifaciens sialidase (PDB ID: 1EUS) (Gaskell et al., 1995) and 
Pseudomonas aeruginosa pseudaminidase (PDB ID: 2W38) (Xu et al., 
2009) was performed. The docked conformation of sialic acid showed a 
root-mean-square (r.m.s.) deviation of 1.5 Å from the co-crystallized 
Neu5Ac2en (2-deoxy-2,3-dideoxy-N-acetylneuraminic acid; a sialic acid 
mimic) in M. viridifaciens sialidase (Gaskell et al., 1995). The binding mode 
of Pse in P. aeruginosa pseudaminidase predicted by the present docking 
calculation was very similar to that of the reported docking result (Xu et al., 
2009). These results validate the present docking method. 
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1.2.5. Peptidase assay by mass analysis 
As potential substrates, synthetic muramyl tetrapeptide (-methyl N-
acetylmuramic acid-L-Ala1-γ-D-Glu2-mDAP3-D-Ala4) and muramyl 
pentapeptide (-methyl N-acetylmuramic acid-L-Ala1-γ-D-Glu2-mDAP3-D-
Ala4-D-Ala5) were prepared as described previously (Lee et al., 2009) 
(Figure 1-4, A and B). The analyte, muramyl tetrapeptide (or muramyl 
pentapeptide) at 5 mM, was incubated for 2 h at 37oC with the recombinant 
Csd6 protein (5 µM), which was dissolved in 20 mM sodium phosphate at 
pH 6.0 and 150 mM sodium chloride. A sample solution (1 μl) was mixed 
on the target with a fresh saturated matrix solution of 2,5-dihydroxy benzoic 
acid dissolved in 0.1% (v/v) trifluoroacetic acid and 50% (v/v) acetonitrile. 
For sample deposition, a 384-position stainless-steel sample plate was used. 
Mass spectra were acquired on a matrix-assisted laser desorption/ionization 
quadrupole ion trap time-of-flight mass spectrometer (MALDI-QIT-TOF 
MS, AXIMA QIT; Shimadzu/Kratos, Manchester, UK) equipped with a 
nitrogen laser (337 nm, 3 ns pulse width, maximum pulse rate 10 Hz). Mass 
spectra were obtained in a positive ion mode. Helium was used for trapping 
and cooling ions in the ion source. The pressure in the trap was held at 
4×10-3 torr. Each spectrum constituted an average of 200 profiles. All 
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spectra were externally calibrated with bradykinin (757.3992 Da), 
angiotensin II (1046.5418 Da), angiotensin I (1296.6848 Da), Glu-
fibrinopeptide B (1570.6768 Da), and N-acetyl renin substrate (1800.9432 
Da) in TOFMixTM (Shimadzu, Japan). Acquisition and data processing were 
controlled by the LanchpadTM software. The m/z values of multiple sodium 
adduct ions from the substrates and products are shown in Figure 1-4, A‒E. 
As a positive control, the peaks were detected corresponding to the dimeric 
crosslinked species between the muramyl tetrapeptide and muramyl 
tripeptide (Figure 1-4C), a product of the LD-TPase reaction catalyzed by 
the recombinant LdtMt2 (Ala55–Ala408). The LD-TPase domain (residues 
Asp251–Val378) of M. tuberculosis LdtMt2 shows sequence identity and 
similarity of 22% and 38%, respectively, with the Csd6 LD-CPase domain 
(residues Lys67–Glu202). 
To evaluate the importance of specific residues in the LD-CPase 
activity of Csd6, each of eight residues in the active-site was mutated into 
alanine: E110A, Y132A, Y133A, H155A, W158A, H160A, and C176A. 
The mutations were verified by DNA sequencing. The wild-type and these 
single mutants of Csd6 were incubated with the substrate muramyl 
tetrapeptide for 30 min at 23oC. Mass spectra were acquired as described 
above. 
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1.2.6. Analytical ultracentrifugation 
To determine the oligomeric state of the recombinant Csd6 in solution, 
equilibrium sedimentation and sedimentation velocity experiments were 
carried out using a Beckman ProteomeLab XL-A analytical ultracentrifuge 
in 20 mM Tris-HCl buffer at pH 7.9 containing 150 mM sodium chloride 
and 1.5 mM tris(2-carboxyethyl)phosphine at 20oC. For the equilibrium 
sedimentation experiment, the absorbance from the Csd6 samples was 
measured at 235 and 280 nm using a six-sector cell at two speeds (16,000 
and 20,000 rpm) and at three different Csd6 monomer concentrations (2.74, 
3.65, and 4.56 μM) with a loading volume of 135 μl. For the sedimentation 
velocity experiment, the Csd6 samples at two different monomer 
concentrations (0.40 and 5.00 μM) were measured in double-sector cells at 
30,000 rpm and the collected data were analyzed by SEDFIT and 
SEDPHAT programs available from www.analyticalultracentrifugation.com. 
The concentration of the recombinant Csd6 protein was calculated using 
ε280nm = 54,780 M-1 cm-1. 
 
1.2.7. Single-molecule fluorescence resonance energy transfer (FRET) 
To analyze the dimeric form of Csd6 in solution, a single-molecule 
FRET technique incorporating alternating-laser excitation (ALEX) was 
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employed (Kim et al., 2012; Lee et al., 2005). Briefly, in this method the 
fluorescence signal of a dimeric molecule is analyzed one-by-one and the 
result is presented in a two-dimensional E-S graph (Figure 1-6D), where E 
is the FRET efficiency and S denotes the Cy3/Cy5 molar ratio in a dimer. 
The Csd6 sample was divided into two aliquots, each of which was labeled 
on the sole cysteine residue (Cys176) with the maleimide-reactive Cy3 dye 
(donor) or the Cy5 dye (acceptor). Subsequently, Cy3-labeled Csd6 (Cy3-
Csd6) and Cy5-labeled Csd6 (Cy5-Csd6) were mixed at 2 μM final 
monomer concentration in a buffer (20 mM Tris-HCl at pH 7.9 and 150 mM 
sodium chloride) for 3 h at 37C. The protein sample was diluted further to 
100 pM using a single-molecule buffer [20 mM Tris-HCl at pH 7.9, 150 
mM sodium chloride, 5% (v/v) glycerol, 1 mM 2-mercaptoethylamine, and 
0.01% (v/v) bovine serum albumin]. The single-molecule data were acquired 
from a 10 min measurement. 
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1.2.8. Surface plasmon resonance experiment 
The kinetics and affinity of Csd6 with the synthetic muramyl 
tetrapeptide and muramyl tripeptide (-methyl N-acetylmuramic acid-L-
Ala1-γ-D-Glu2-mDAP3) as a reaction product was assessed using a Reichert 
SR7500 Surface Plasmon Resonance (SPR) dual channel instrument 
(Reichert, Depew, NY). Purified Csd6 in 20 mM sodium acetate at pH 5.5 
was immobilized using the standard amino coupling at 20 μl min-1 on a 
carboxymethyl dextran hydrogel surface sensor chip (Reichert, Depew, NY) 
until saturation was achieved. The running buffer B used in all SPR 
experiments was 20 mM HEPES at pH 7.9 and 150 mM sodium chloride. 
SPR experiments were performed at 25C. The muramyl tetrapeptide or 
muramyl tripeptide at concentrations of 15.6, 31.3, 62.5, 125, 250, and 500 
μM was injected over the Csd6-chip at 30 μl min-1 for 5 min for association 
analyses. Subsequently, the running buffer was flowed over the chip for 
additional 6 min (30 μl min-1) for dissociation analyses. Regeneration of the 
chip was carried out using 20 mM sodium hydroxide. Binding was detected 
as a change in the refractive index at the surface of the chip as measured by 
the response unit (RU). A reference flow cell was used to record the 
response by bovine serum albumin (BSA) as a positive control, and the 
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response by BSA was subtracted from each sample. SPR data were fit using 




1.3.1. Csd6 functions as an LD-CPase but not as an LD-TPase 
To verify the molecular function of H. pylori Csd6 in peptidoglycan 
modification, the peptidase activity of Csd6 was measured in vitro with the 
synthetic muramyl tetrapeptide and muramyl pentapeptide (Figure 1-4, A 
and B) as potential substrates using mass analyses. When the muramyl 
pentapeptide was incubated with the recombinant Csd6 (13–330), no 
reaction product could be detected (Figure 1-4E). This suggests that Csd6 
does not have ‘endo’-, ‘DD-carboxy’- or ‘LD-trans’-peptidase activities 
with the muramyl pentapeptide. The LD-CPase domain of Csd6 shows 
limited but significant sequence identity (22%) with the LD-TPase domain 
of M. tuberculosis LdtMt2. M. tuberculosis LdtMt2 is a functional LD-TPase, 
catalyzing the formation of 3→3 cross-links between the muramyl 
tetrapeptide and the muramyl tripeptide (Cordillot et al., 2013). Therefore, 
as a positive control for measuring the LD-TPase activity, the muramyl 
tetrapeptide was incubated with the recombinant M. tuberculosis LdtMt2. In 
this control reaction, not only the muramyl tripeptide (‘Tri’ in Figure 1-4C) 
but also the dimeric cross-linked species (‘Tetra-Tri’ in Figure 1-4C) were 
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detected as the reaction products. In comparison, when the muramyl 
tetrapeptide was incubated with the recombinant Csd6, the muramyl 
tripeptide was detected as the sole reaction product, without any dimeric 
cross-linked species (Figure 1-4D). This result implies that Csd6 would not 
be active for cross-linking, if the muramyl tripeptide were used as a 
substrate. The present data, together with the previous report that Csd6 
converts monomeric tetrapeptides of the peptidoglycan sacculus into 
tripeptides (Sycuro et al., 2013), clearly establish that H. pylori Csd6 
functions as an LD-‘carboxypeptidase’ devoid of a cross-linking LD-TPase 
despite the presence of the conserved Cys/His residues, which are 
characteristics of the ‘LD-TPase’ domains. The active-site features of Csd6, 
































(A and B) Mass spectra and structural formulas of the synthesized muramyl 
tetrapeptide (A) and muramyl pentapeptide (B). The observed peaks 
correspond to a series of sodium adduct ions of the peptides. (C–E) Mass 
spectra of the peptide samples upon incubation with LdtMt2 and Csd6. In the 
control reaction catalyzed by LdtMt2, the dimeric cross-linked tetra-tripeptide 
species is produced from the muramyl-tetrapeptide (C). In contrast, in the 
reaction catalyzed by Csd6, the muramyl-tetrapeptide is converted to the 
muramyl-tripeptide but not to dimeric cross-linked tetra-tripeptide species 
(D). Upon incubation with Csd6, the muramyl-pentapeptide undergoes no 
change (E). The observed m/z values for the charged species with bound 
sodium ions (up to four: [M+Na]+1, [M+2Na-H]+1, [M+3Na-2H]+1, and 
[M+4Na-3H]+1) agree with the calculated m/z values for muramyl-tri, 
muramyl-tetra, muramyl-penta, or dimeric cross-linked tetra-tripeptides 
(average mass of neutral species = 679.67, 750.75, 821.83, or 1412.41, 
respectively). 
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1.3.2. The Csd6 monomer is organized into three-domain architecture 
To provide a structural basis of understanding the molecular function, the 
crystal structures of Csd6 have been determined, both in the ligand-free 
state (‘Csd6-unbound’) (Figure 1-5) and in the D-Ala-bound state (‘Csd6-
Ala’) (Table 1). Refined models of both structures are essentially identical 
to each other with an r.m.s. deviation of 0.17 Å for 632 equivalent Cα 
positions. They account for residues Met15–Lys330 in each of two Csd6 
monomers in an asymmetric unit (ASU). In the case of Csd6-unbound 
structure, two monomers in the ASU are similar to each other with an r.m.s. 
deviation of 0.64 Å for 316 Cα atom pairs, except N-terminal residues 
(Leu15–Asp41) showing r.m.s. deviations greater than 1.0 Å with a 
maximum Cα deviation (7.6 Å) at Leu15. For the Csd6-Ala model, two 
monomers in the ASU agree with an r.m.s. deviation of 0.61 Å for 316 Cα 
atom pairs, except N-terminal residues (Leu15–Asp41) showing r.m.s. 
deviations greater than 1.0 Å with a maximum Cα deviation (8.4 Å) at 
Leu15. The amino-acid residues with the largest deviation encompass the 




Figure 1-5. Overall structure of H. pylori Csd6 
The ribbon diagram (left panel) and topology diagram (right panel) of the 
Csd6-unbound structure. The NTD, LD-CPase domain, and NTF2-like 
domain are shown in red, green, and yellow, respectively. The secondary 
structure elements have been defined by the DSSP program (Kabsch and 
Sander, 1983). The nucleophile Cys176 of the LD-CPase domain is shown in 
a cyan stick model.  
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The Csd6 monomer consists of three domains of unequal size: the NTD 
(Val13–Asn56), the middle LD-CPase domain (Lys67–Glu202), and the C-
terminal NTF2-like domain (Thr209–Lys330) (Fig. 1-5). The NTD consists 
of three alpha helices (αA–αC) and the helix αC is positioned at one end of 
the antiparallel coiled-coil formed by helices αA and αB. The LD-CPase 
domain consists of two curved β-sheets (β3-β2-β1-β8-β4 and β4-
β5-β6-β7), which share the β4 strand, as well as two α-helices (αD and 
αE). The NTF2-like domain forms an antiparallel four-stranded β-sheet 
(β9-β10-β11-β12), whose concave side is packed by three α-helices 
(αF–αH). DALI structural similarity searches (Holm and Rosenström, 2010) 
revealed no significant match with either the entire Csd6 with three domains 
or any combination of two connected domains in Csd6, suggesting that the 
three-domain architecture of Csd6 is unique. This is in line with our 
observation that the organization of the LD-CPase domain and the NTF2-
like domain in Csd6 and its homologs is unique among the LD-TPase and 
LD-CPase families according to the conserved domain searches using the 
InterPro database (Mitchell et al., 2015). 
In the Csd6 monomer structure, three domains are arranged in a 
tripartite, leaf-like fashion with a single chain connecting two adjacent 
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domains (Figure 1-5). Virtually no interaction exists between the NTD and 
the LD-CPase domain; the buried surface area at the interface is only 36 Å2, 
as calculated by the PISA server (Krissinel and Henrick, 2007). Much more 
extensive interactions exist between the LD-CPase domain and the NTF2-
like domain, with a buried surface area of 718 Å2. The latter interface is 
mainly formed between strands β4 and β8 of the LD-CPase domain, and 
strands β9–β11 of the NTF2-like domain. It is primarily lined with 
hydrophobic residues of both domains (Val119, Tyr120, Tyr146, Phe197, 
and Ile199 of the LD-CPase domain and Ile278, Tyr280, Tyr290, Val292, 
and Tyr316 of the NTF2-like domain). The NTD (helix αC) and the NTF2-
like domain (helix αF) interact with each other, burying a surface area of 
410 Å2 at the interface. 
 
1.3.3. The NTD of Csd6 plays a dominant role in homo-dimerization 
Equilibrium sedimentation measurements indicate that the Csd6 protein 
exists as homogeneous dimers in solution (at the tested Csd6 monomer 
concentration range of 2.74–4.56 μM). The data fit well to a dimer model 
and a representative result measured at 16,000 rpm using the 3.65 μM 
monomer concentration is presented in Figure 1-6A. Further sedimentation 
velocity experiments at 0.40 and 5.00 μM Csd6 monomer concentrations 
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also indicate the oligomeric state of Csd6 as a dimer, without any 
discernable dissociation of a dimer into monomers, down to 0.40 μM 
(Figure 1-6C).  In the crystal of Csd6, two possible models of the dimer 
could be identified. The dimer model I has a buried surface area of 1,080 Å2 
per monomer (6.7% of the monomer surface area) at the interface, as 
analyzed by the PISA server (Krissinel and Henrick, 2007), (Figure 1-6B, 
the upper panel). In the dimer model I, the two monomers are related by 
non-crystallographic ‘pseudo’ two-fold symmetry. The two-fold symmetry 
is broken primarily by the significant difference in the orientation of N-
terminal helices αA and αB between the two monomers. The dimer model II 
has a buried surface area of 726 Å2 (4.5% of the monomer surface area) 
(Figure 1-6B, the lower panel). In the dimer model II, the two monomers are 
related by an exact crystallographic two-fold symmetry. The ΔiG values 
(solvation free energy gain upon formation of the interface) are -15.8 and -
2.1 kcal mol-1 for models I and II, with the Complexation Significance 
Scores (CSS) of 1.000 and 0.000, respectively. These CSS values imply that 
the interface in model I, but not in model II, plays an essential role in 
complex formation. Therefore, I conclude that the dimer model I in the 
crystal represents the biologically relevant Csd6 dimers in solution. This 
conclusion experimentally by the distance between two Cys176 residues in 
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the dimer as estimated using the single-molecule ALEX-FRET technique 
(Figure 1-6D). The single-molecule ALEX-FRET experiment was 
performed at 100 pM monomer concentration, which is much lower than 
those used for analytical ultracentrifugation, to avoid ensemble averaging 
(i.e., to avoid the case of having two non-interacting species) (Hohlbein et 
al., 2014). After direct excitation leakage and buffer background corrections, 
the distance between Cy3 and Cy5 dipoles in the dye-labeled Csd6 dimer is 
estimated to be 107 Å from the corrected FRET efficiency (Ecorr ≈ 0.03), 
using Ro (Förster distance) of 60 Å for the Cy3 and Cy5 pair. In the crystal 
structure of Csd6-unbound, the distance between sulfur atoms of two 
Cys176 residues is 96 Å and 66 Å in dimer models I and II, respectively. 
This result unambiguously favors model I, supporting the assignment of 






Figure 1-6. Oligomeric state of H. pylori Csd6 
(A) Equilibrium sedimentation data for Csd6 at an ultracentrifugal speed of 
16,000 rpm using 3.65 μM protein at 20oC. The circles are experimental 
data and the solid line is a fitting line for an ideal monomer model. The two 
dotted lines are fitting lines for an ideal monomer and trimer models. 
Distributions of the residuals for monomer, dimer, and trimer models are 
shown in the inset panel. These data indicate that Csd6 exists as 
homogeneous dimers in solution. (B) Two putative models of the Csd6 
dimer in the crystal. Dimer model I (upper panel) and model II (bottom 




are shown as purple spheres. Model I is favored by the single-molecule 
ALEX-FRET data (shown in Figure 1-6D). (C) Plots of the residuals for 
dimer species model of Csd6 at 0.40 μM (upper) and 5.00 μM (lower), and 
the distribution of sedimentation coefficient (c(s) versus s, where s is in 
Svedberg unit, S) from the sedimentation velocity experiments. (D) 
Determination of the dimeric model of Csd6 by single-molecule FRET 
technique. Single-molecule FRET data are presented in a 2-dimensional 
(2D) E-S graph, where E is the FRET efficiency and S denotes the Cy3 
(donor)/Cy5 (acceptor) molar ratio in a dimer (Kim et al., 2012). Three 
clusters correspond to the dimers formed (i) between two Cy3-Csd6 
monomers, (ii) between two Cy5-Csd6 monomers, and (iii) between a Cy3-
Csd6 monomer and a Cy5-Csd6 monomer. The cluster appearing at S ~ 1 
(green dotted ellipse) with E ≈ 0 corresponds to Cy3-labeled Csd6 dimers. 
Csd6 dimers labeled with both Cy3 and Cy5 appear at S ~ 0.5 (orange 
dotted ellipse) (Lee et al., 2005).  
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The Csd6 dimer (i.e., dimer model I) is elongated with approximate 
dimensions of 100 Å × 80 Å × 50 Å (Figure 1-7A). In this dimer, two LD-
CPase domains are well separated from each other and their active-sites are 
open toward the bulk solvent (Figure 1-7A). The bulk of the buried surface 
area at the dimerization interface is contributed by the NTD (82.7%), with 
the linker between the NTD and the LD-CPase domain contributing 5.7% 
and the NTF2-like domain contributing 11.6%. The N-terminal helix αA of 
the NTD takes slightly different conformations in the two monomers, with a 
maximum Cα deviation of 7.6 Å at Leu15. The two NTDs pack against each 
other through their antiparallel coiled-coils (helices αA and αB), at an angle 
of about 60°, to form a four-helix bundle (Figure 1-7A); numerous 
hydrophobic side chains are present at the interface. The αC-helices from 
two NTDs cover the sides of the four-helix bundle. Seven hydrogen bonds 
(involving Arg26, Tyr28, Gln29, Gly37, Asp41, Glu53, Tyr63, Gln65, and 
Phe272) and a salt bridge (involving Arg26 and Glu53) exist at the interface 
(Figure 1-7B). Interestingly, the Csd6 dimer has a deep crevice of an 
approximate size of 20 Å by 20 Å, with a widened bottom (indicated by 
dotted lines in Figure 1-7C). The NTDs provide the bottom of the crevice 
and the C-terminal NTF2-like domains form the two sides of the crevice. 
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The sides of the crevice are lined with positively charged residues (Lys267, 




Figure 1-7. Dimeric structure of H. pylori Csd6 
(A) The ribbon diagram of the Csd6 homodimer (model I) colored as in 
Figure 1-5. In this dimer, A and B monomers are related by a non-
crystallographic pseudo two-fold symmetry. (B) Hydrophobic interactions 
between the NTDs of A and B monomers, which are shown in the ribbon 
diagram and the electrostatic surface diagram, respectively. (C) Electrostatic 
potential surface diagrams of the Csd6 dimer molecule. A detailed view of 





A DALI search with the Csd6 NTD (Val13–Asn56) alone showed very 
remote structural similarities to other known protein structures. The highest 
Z-score was obtained with human phosphatidylinositol 4,5-bisphosphate 3-
kinase catalytic subunit alpha isoform (PDB code 4L2Y-A; an r.m.s. 
deviation of 2.1 Å for 41 equivalent Cα positions in residues 16–56, a Z-
score of 4.6, and a sequence identity of 5%). The Csd6 NTD is perhaps 
functionally more related to the L27N domain of Mus musculus PALS1-
associated tight junction protein (PDB code 1VF6-D; an r.m.s. deviation of 
4.2 Å for 41 equivalent Cα positions in residues 16–56, a Z-score of 4.3, and 
a sequence identity of 12%) (Li, et al., 2004). L27 domains, such as PALS1-
L27N, have been established as a protein-binding module that brings 
multiple proteins into complexes for signaling, cell polarity, and epithelial 
morphogenesis (Doerks et al., 2000; Harris et al., 2002). Like the Csd6 NTD, 
the L27 domain is composed of three α-helices. However, unlike the Csd6 
NTD that plays a key role in homo-dimerization, two different L27 domains 
(e.g., PALS1-L27N domain and PATJ-L27) hetero-dimerize by building a 
compact four-helix bundle structure through the first two helices from each 






Figure 1-8. Comparisons of the Csd6 NTD with the PALS1-L27N 
domain 
The following pairwise superimpositions are shown in ribbon diagrams: (A) 
the NTD of the Csd6 monomer A and the PALS1-L27N domain, (B) the 
NTDs of Csd6 monomers A and B, and (C) the NTDs of the Csd6 dimer 




1.3.4. Active-site of Csd6 LD-CPase domain is tailored for the LD-CPase 
activity 
A bioinformatics analysis on the basis of amino-acid sequence predicts 
H. pylori Csd6 to have an overall fold of the LD-TPase catalytic domain 
over residues 67–200. The structure reported here validates this prediction 
(Figures 1-5 and 1-9A). However, this catalytic domain is referred to as the 
LD-CPase domain, because Csd6 is shown to function only as an LD-CPase, 
but not as an LD-TPase against the muramyl tetrapeptide. According to the 
DALI search, the overall fold of the Csd6 LD-CPase domain (Lys67–
Glu202) (Figure 1-9A) resembles those of well-characterized LD-TPases 
such as B. subtilis LdtBs (Figure 1-9B) (PDB code 1Y7M; a Z-score of 14.8, 
an r.m.s. deviation of 1.8 Å, and a sequence identity of 13% for 109 
equivalent Cα positions) (Bielnicki et al., 2006), E. faecium Ldtfm (Figure 1-
9C) (PDB code 1ZAT; a Z-score of 12.1, an r.m.s. deviation of 2.7 Å, and a 
sequence identity of 14% for 111 equivalent Cα positions) (Biarrotte-Sorin 
et al., 2006), and M. tuberculosis LdtMt2 (Figure 1-9D) (PDB code 4GSU; a 
Z-score of 11.7, an r.m.s. deviation of 2.1 Å, and a sequence identity of 14% 
for 107 equivalent Cα positions) (Kim et al., 2013). Unlike Csd6, all of 
these LD-TPases are monomeric enzymes (Biarrotte-Sorin et al., 2006; Kim 
et al., 2013; Bielnicki et al., 2006). Furthermore, the LD-CPase domain of 
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Csd6 contains the characteristic sequence motif H(S/G/D)x14~19C (Figure 
1-9E), where ‘x’ stands for any amino acid and the strictly conserved 
residues are in boldface. This motif is conserved among proteins containing 
an LD-TPase catalytic domain and provides the catalytic triad residues, 
which form a hydrogen-bond network in a wide range of Cys/Ser-based 
proteolytic enzymes (Dodson and Wlodawer, 1998). The catalytic triad of 
Csd6 consists of His160, Gly161, and Cys176 (marked by red dots in Figure 
1-9E), corresponding to His336, Ser337, and Cys354 of LdtMt2 (Kim et al., 
2013). However, H. pylori Csd6 is unrelated in its sequence and structure to 
previously-characterized LD-CPases such as L,D-carboxypeptidases A 
(LdcA) from Pseudomonas aeruginosa (Korza and Bochtler, 2005) and 
Novosphingobium aromaticivorans DSM 12444 (Das et al., 2013), and L,D-
carboxypeptidases B (LdcB) from Streptococcus pneumoniae, Bacillus 
anthracis, and Bacillus subtilis (Hoyland et al., 2014). LdcA is a Ser-based 
LD-CPase. The latter three LdcB proteins belong to the LAS (lysostaphin, D-
Ala-D-Ala metallopeptidases, sonic hedgehog) family of Zn2+-dependent 
peptidases (Hoyland et al., 2014). This raises an intriguing question why H. 
pylori Csd6 functions only as an LD-CPase, but not as an LD-TPase, despite 




Figure 1-9. Comparison of Csd6 and other LD-TPases 
(A–D) the ribbon diagrams (left panels) and surface diagrams (right panels) 
of the LD-CPase domain of H. pylori Csd6 (A) and the LD-TPase domains of 
B. subtilis LdtBs (B), E. faecium Ldtfm (C), and M. tuberculosis LdtMt2 (D). 
The four loops I, II, III, and IV are colored in yellow, green, light blue, and 
purple, respectively. One or two paths that allow access to the catalytic triad 
are indicated by red arrows. In the meropenem-complexed LdtMt2 structure 





respectively (Kim et al., 2013). Meropenem was modeled into each domain 
structure by structural superimposition of the corresponding domains using 
the meropenem-complexed LdtMt2 (PDB code: 4GSU). (E) Structure-based 
sequence alignment was performed by PROMALS3D (Pei et al., 2008) and 
the alignment was presented by GeneDoc 
(http://www.nrbsc.org/downloads). Structures of the LD-CPase domain of H. 
pylori Csd6 (SWISS-PROT accession code: O25255; PDB code: 4XZZ) and 
LD-TPase catalytic domains of B. subtilis LdtBs (O34816; 1Y7M), E. 
faecium Ldtfm (Q3Y185; 1ZAT), and M. tuberculosis LdtMt2 (O53223; 
4GSU) were used in the alignment. In the case of C. jejuni Pgp2 (A1VZP0), 
no structural information is available and thus only the sequence is used. 
Red dots indicate the catalytic triad (His160, Gly161, and Cys176 in H. 
pylori Csd6). The four loops I, II, III, and IV are shown in colored boxes as 
in Figure 1-9A. 
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A structural comparison of Csd6 LD-CPase domain with LD-TPase 
domains reveals that the shape of the active-site in the Csd6 LD-CPase 
domain seems to be tailored for the L,D-carboxypetidation. That is, the 
active-site is a deep pocket and the catalytic triad positioned at the bottom of 
this pocket is accessible via a single narrow path (Figure 1-9A), as in typical 
carboxypeptidases (Covaleda et al., 2012). In contrast, the active-site in the 
corresponding domains of the above three LD-TPases is an elongated groove 
and the catalytic triad is accessible via two paths (Figure 1-9, B–D) (Kim et 
al., 2013). The different shapes of the active-sites are primarily dictated by 
the length and conformation of the loops around the entrance(s) to the 
active-sites. Structural comparison and sequence alignment of Csd6 LD-
CPase domain with the corresponding domains of three LD-TPases (Figure 
4) show that unique features of Csd6 that distinguish it from other LD-
TPases reside primarily in four loop regions: loop I (β3-β4 loop; Ala98–
Ile117), loop II (β4-β5 loop; Leu126–Leu136), loop III (β5-αD-β6 loop; 
Asn141–Ile157), and loop IV (β6-β7 loop; Met162–Cys176). 
The reaction catalyzed by LD-TPases such as LdtMt2 occurs in two 
sequential steps: acylation of the donor substrate (“carboxypeptidation”) and 
deacylation by the acceptor substrate for cross-linking (“transpeptidation”) 
(Silva et al., 2014). As a consequence, LD-TPases such as LdtMt2 have two 
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accessible paths for donor and acceptor substrates (indicated by red arrows 
in Figure 1-9, B–D), thereby allowing an approach of the acceptor substrate 
upon acylation of the donor substrate by the catalytic Cys residue for 
transpeptidation. For a better understanding of the substrate-binding site 
(Figure 1-9, A–D), meropenem (mimicking the substrate) onto Csd6 by 
superimposing its LD-CPase and the LD-TPase domain of the meropenem-
complexed LdtMt2 (Kim et al., 2013). The position of the covalently bound 
meropenem represents the path for the donor substrate (‘path A’). The 
active-site clefts in three LD-TPases reveal a long groove for binding two 
substrates, which is contributed by the four loops I–IV (Figure 1-9, B–D). In 
LdtMt2 and Ldtfm, the extended loop II (green colored in Figure 1-9, C and 
D) forms a lid to cover the active-site cleft, while exposing two discrete 
paths for the access of two substrates. On the other hand, the loop II of LdtBs 
is much shorter and the active-site cleft is not covered with a lid (green 
colored in Figure 1-9B). Like LdtBs, the loop II is much shorter in Csd6 and 
the active-site cleft is not covered with a lid. However, in the Csd6 structure, 
the corresponding paths to the active-site cleft for access of two substrates 
in three LD-TPases are blocked due to the distinct length and conformations 
of the loops I–IV and the active-site cleft opens vertically towards the 
solvent (indicated by a red arrow in Figure 1-9A), allowing access of only 
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one muramyl peptide for carboxypeptidation. This difference in the shape of 
the active-site cleft is the likely reason for the enzyme serving as a 
carboxypeptidase, to the exclusion of the transpeptidase activity. 
Among the four loops I–IV, the loops I and III show the most distinct 
variations in sequence length and conformation. They are considerably 
longer (eight and twelve residues, respectively) in H. pylori Csd6 than in the 
LD-TPases (Figure 1-9E). Loop III contains the helix αD, which protrudes 
from the active-site. Together with loop I, it provides one side of the active-
site cleft to recognize a substrate. The C. jejuni Pgp2, a Csd6 homolog, is 
predicted to contain an LD-TPase domain on the basis of its amino acid 
sequence (Figure 1-9E) but it was shown to function as an LD-CPase 
(Frirdich et al., 2014). I notice that the four loops of Pgp2 show a highly 
similar pattern with those of Csd6 (Figure 1-9E). Therefore, it is anticipated 
that the observed unique structural features of these four loops around the 
active-site cleft are conserved among Csd6 homologs in other ε-
proteobacteria. 
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1.3.5. D-Ala-complexed structure reveals binding modes of both the 
substrate and product 
By analogy with the first carboxypeptidation step of LdtMt2, His160 of 
Csd6 serves as a proton acceptor to assist a nucleophilic attack by Cys176. 
In present Csd6 structure, the side chains of His160 and Cys176 are suitably 
predisposed for a cooperative action with the main-chain carbonyl of 
Gly161 (Figure 1-10A). His160Nε2 interacts with Cys176Sγ with a distance 
of 3.96 Å and His160Nδ1 interacts with the main-chain oxygen atom of 
Gly161 with a distance of 2.75 Å (Figure 1-10A). In addition, the LD-CPase 
domain of Csd6 shows a well-defined oxyanion hole to facilitate catalysis. 
The backbone amide nitrogen atoms of Lys174, Gly175, and Cys176 
(asterisked in Figure 1-10A) could stabilize the transient oxyanion species 
of the polarized carbonyl bond, as in LdtMt2 (Silva et al., 2014). 
In order to understand the structural determinants for ligand binding, the 
structure of Csd6 bound with the product D-Ala (‘Csd6-Ala’ in Table 1) was 
determined. In the Csd6-Ala model, two D-Ala molecules are well 
ensconced within the active-site of monomer A with clear electron density 
(marked as D-Ala′ and D-Ala″ in Figure 1-10A), while only one D-Ala 
molecule is present in monomer B at the corresponding position as D-Ala′ in 
monomer A. The different binding states of monomers A and B in the 
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crystal seem to be correlated with the oxidation state of Cys176. Its side 
chain is oxidized to sulfenic acid only in monomer A, as indicated by the 
extra electron density (C176OH in Figure 1-10A). An oxygen atom of 
sulfenic acid possibly stabilizes the weak binding of the product D-Ala″N in 
monomer A. D-Ala′ is located between loops I and III, whereas D-Ala″ is 
trapped by loops II, III, and IV, right in front of the nucleophile Cys176. D-
Ala′ is too far from the predicted site of the scissile bond for Cys176 to act, 
but it interacts with Lys107Nζ, Glu110Oε2, His155N,O,Nδ1, and Gly111N, as 
well as Lys174N and the main-chain oxygen atom of Leu113 via a water 
molecule. Interestingly, the side-chain portion of mDAP, part of the Csd6 
substrate muramyl-L-Ala1-γ-D-Glu2-mDAP3-D-Ala4, is structurally identical 
to a D-Ala molecule. Therefore, I suggest that D-Ala′ and D-Ala″ represent 
the mDAP portion of the substrate and the end product, D-Ala, respectively, 
for the link between mDAP3 and D-Ala4 (the scissile peptide bond) of the 
muramyl tetrapeptide. mDAP was modeled into the Csd6 LD-CPase domain 
on the basis of the positions of D-Ala′ and Wat1 bound in the oxyanion hole. 
The modeled mDAP fits well into the active-site cleft (bottom panel of Fig. 
4A). It makes proper interactions with the oxyanion hole and is suitably 
positioned for a nucleophilic attack by Cys176, thus providing the substrate 
binding mode. Dissociation constants (KD) of Csd6 for its complex with D-
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Ala (or mDAP) have also been measured to be 224 (or 94) μM using SPR 
measurements. The measured association and dissociation rate constants (ka 
and kd) are 1.05 M-1s-1 and 2.3010-4 s-1 for D-Ala and 1.49 M-1s-1 and 





Figure 1-10. D-Ala-complexed Csd6 and key residues for the LD-CPase 
activity 
(A) The ribbon diagram and the accessible inner surface of the active-site in 
the Csd4-Ala structure. The bound D-Ala molecules (D-Ala′ and D-Ala″) 
(upper panel) and the mDAP (bottom panel) modeled on the basis of D-Ala′ 
and Wat1 are shown in stick models. The omit mFo-DFc maps for D-Ala′ 
and D-Ala″ (contoured at 2.0σ) and the side chain oxygen atom of Cys176 
oxidized as the sulfenic acid (contoured at 2.5σ) are colored in blue. The 




bottom panel. Red dotted lines indicate the interactions among residues of 
the catalytic triad. (B) The L,D-carboxypeptidation activities of the wild-type 
Csd6 (with the treatment of EDTA or not) and the mutants (E110A, Y132A, 
Y133A, H155A, W158A, H160A, and C176A) with the muramyl 
tetrapeptide. (C) SPR experiments with immobilized Csd6 and the muramyl 
tetrapeptide (or muramyl tripeptide) as an analyte at different concentrations 
(15.6, 31.3, 62.5, 125, 250, and 500 μM) are shown in traces colored as 
orange, light blue, purple, green, red, and blue, respectively. 
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To further confirm the role of potential key residues in the active-site 
cleft, eight single amino-acid mutant proteins (E110A, Y132A, Y133A, 
H155A, W158A, H160A, and C176A) were prepared. When the L,D-
carboxypeptidation activities of the wild-type Csd6 and the mutants against 
the muramyl tetrapeptide for a limited time (30 min) were compared, 
mutation of Glu110, Tyr133, His155, and Trp158, as well as His160 and 
Cys176 that belong to the catalytic triad, resulted in a complete loss of the 
L,D-carboxypeptidation activity (Figure 1-10B). Glu110, Tyr133, and 
Trp158 are strictly conserved in C. jejuni Pgp2 as well (Figure 1-9E). Lack 
of L,D-carboxypeptidation activity in E110A and H155A mutants supports 
that Glu110 and His155 recognize the side chain of mDAP, as shown in D-
Ala′ bound to Csd6 and mDAP modeled into the position of D-Ala″ (Figure 
1-10A). Trp158 holds the aliphatic side chain of D-Ala″, whereas Tyr133 
likely interact with the main chain of mDAP, possibly via a water molecule 
such as Wat2 in Figure 1-10A. Meanwhile, the retained activity of the 
Y132A mutant indicates that Tyr132 is not important for the L,D-
carboxypeptidation activity of Csd6 (Figure 1-10B). The L,D-
carboxypeptidation activity of Csd6 is independent of metal ions, as there is 
no change upon EDTA treatment (Figure 1-10B). 
 60
To estimate the kinetics and affinity of Csd6 with the muramyl 
tetrapeptide (as a substrate) and muramyl tripeptide (as a product), SPR 
experiments were conducted. The association rate constant (ka) and the 
dissociation rate constant (kd) for the muramyl tripeptide are roughly three-
times and fifty-times larger than those for the muramyl tetrapeptide, 
respectively (Figure 1-10C). As a consequence, KD values for the muramyl 
tetrapeptide and the muramyl tripeptide are 27.0 μM and 510 μM, 
respectively, indicating that the muramyl tripeptide dissociates readily from 
Csd6 as the product of Csd6-catalyzed LD-CPase reaction. This result is also 
consistent with the muramyl tripeptide not being used as the substrate for 
the possible LD-TPase cross-linking reaction in the subsequent step. 
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1.3.6. The C-terminal NTF2-like domain has a putative binding pocket 
for pseudaminic acid 
H. pylori Csd6 is distinct from the known LD-TPases by having a C-
terminal NTF2-like domain (residues Thr209–Lys330), following its LD-
CPase domain. The combination of these two domains is conserved in the 
so-called ErfK/YbiS/YcfS/YnhG family proteins from both Helicobacter 
and Campylobacter species (Figure 1-11). It was reported that csd6 gene-
deficient transposon mutants of H. pylori G27 exhibited altered motility in 
comparison to its parental strain and the altered pattern of motility resulted 
from elevated levels of O-linked FlaA Pse-glycosylation of flagellin 
(Asakura et al., 2010). H. pylori flagellin filaments are post-translationally 
modified by glycosylation with Pse, a nine carbon sugar derivative that 
resembles sialic acid, which is typically found on mammalian cell surfaces 
(Figure 1-12B) (Schirm et al., 2003; Logan, 2006). The transposon 
insertions causing the altered motility were located at either positions +765 
bp or +803 bp from the 5’ terminus of the csd6 gene (Asakura et al., 2010), 
corresponding to the region encoding the NTF2-like domain. Furthermore, 
the recombinant H. pylori G27 Csd6 protein expressed in E. coli was 
capable of deglycosylating the purified FlaA protein (Asakura et al., 2010). 
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These results suggest a possible function of the Csd6 NTF2-like domain as a 
deglycosylase, i.e., pseudaminidase. 
The present structure shows that the overall-fold of the Csd6 NTF2-like 
domain differs from other non-viral sialidase or pseudaminidase of the six-
bladed β-propeller fold (Xu et al., 2009; Kim et al., 2011). Instead, it is 
shared with other NTF2-like superfamily members such as the Magnaporthe 
grisea scytalone dehydratase (Motoyama et al., 2002) (PDB code 1IDP; a Z-
score of 14.3, and a sequence identity of 8% for 118 equivalent Cα 
positions), Pseudomonas putida Δ5-3-ketosteroid isomerase (Kim et al., 
1997) (PDB code 1OPY; a Z-score of 12.0, and a sequence identity of 8% 
for 103 equivalent Cα positions), and Rhodococcus sp. naphthalene 
dioxygenase (Gakhar et al., 2005) (PDB code 2B1X; a Z-score of 14.1, and 
a sequence identity of 7% for 116 equivalent Cα positions) (Figure 1-12A). 
None of these enzymes bears any significant sequence or functional 
homology to each other, except that they share common hydrophobic 
substrates. This suggests that the fold of NTF2-like proteins may be a 
suitable scaffold for building a pocket to bind hydrophobic ligands. 
Although the Csd6 NTF2-like domain differs considerably from these 
enzymes in the sequence and the potential function, it shares a deep, largely 
hydrophobic pocket that is open to the solvent (Figure 1-12, A and C). This 
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potential ligand-binding pocket is lined with numerous hydrophobic 
residues (Trp223, Trp227, Tyr235, Tyr239, Phe243, Tyr246, Tyr257, 
Tyr297, and Tyr307). In addition, four positively charged residues (Arg245, 
Lys258, Lys268, and Lys313), and a negatively charged residue (Glu329) 
are located within the pocket. The bold-faced residues are strictly conserved 
in Csd6 homologs in -proteobacteria (Figure 1-11). The pocket is 
somewhat elongated in its shape, unlike hemispherical pockets in scytalone 
dehydratase and Δ5-3-ketosteroid isomerase (Figure 1-12, A and C). The 
Csd6 NTF2-like domain is highly basic with calculated pI of 9.4; the 
electrostatic potential surface shows a highly positively charged surface 
around its deep pocket (Figure 1-12A), compared to the above three NTF2-
like superfamily enzymes. 
In light of the previous report that H. pylori Csd6 is involved in the 
deglycosylation of flagellin (Asakura et al., 2010) and the presence of a 
deep pocket in the NTF2-like domain of Csd6 for possible binding of a 
hydrophobic ligand with an acidic group(s) such as Pse, an in silico docking 
study has been performed. It shows that Pse can fit well into the pocket of 
the NTF-like domain (Figure 1-12C). However, it remains to be determined 

































Sequence alignment of Csd6 homologs from H. pylori strain 26695 
(HP0518; SWISS-PROT accession code: O25255), from Wolinella 
succinogenes (Q7MRJ6), from Arcobacter nitrofigilis (D5V196), from 
Campylobacter concisus strain 13826 (A7ZCK9), and from Thermovibrio 
ammonificans (E8T4Z0) was performed and presented by ClustalX (Larkin 
et al., 2007) and ESPript (http://espript.ibcp.fr) (Gouet et al., 2003). The 
secondary structure of Csd6 is presented above the aligned sequences. The 
four loops IIV around the active site of the Csd6 LD-CPase domain are 




Figure 1-12. The NTF-like domain of Csd6 
(A) Ribbon diagrams and electrostatic potential surface diagrams of the 
NTF-like domains of Csd6, scytalone dehydratase, Δ5-3-ketosteroid 





and (D), In silico docking of Pse onto the pocket in the NTF-like domain of 
Csd6. The potential binding pocket is shown in surface representation (C) 




 I have determined the first crystal structure of Csd6, one of the cell-
shape determining proteins in H. pylori. Each of its three domains is 
associated with a distinct function. The NTD plays a dominant role in 
homo-dimerization. The C-terminal NTF2-like domain has a putative 
binding pocket for Pse. The central LD-CPase domain has the ‘LD-TPase’ 
fold but the shape of its active-site pocket explains why Csd6 possesses only 
the L,D-carboxypeptidation activity despite the presence of the conserved 
catalytic residues for the potential transpeptidase reaction. 
H. pylori Csd6, as well as its close homolog Pgp2 from C. jejuni, 
contribute to the helical morphology of the cells. Interestingly, H. pylori 
Csd6 and C. jejuni Pgp2 are unrelated in their sequence and structure to 
previously-characterized LD-CPases such as LdcA and LdcB from other 
microorganisms. They are thus presumed to form a third family of LD-
CPases. However, it is currently impossible to assign and distinguish 
genuine LD-TPases from the functional LD-CPases via bioinformatics 
analyses of amino-acid sequences alone. The finding that Csd6-specific 
active-site loops I and III are much longer than the corresponding loops in 
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known LD-TPases (Figure 1-9E) enables one to distinguish LD-CPases 
possessing the ‘LD-TPase’ fold from bona fide LD-TPases. Indeed, when 
amino-acid sequences of Csd6 homologs in ε-proteobacteria are aligned, 
Csd6-specific loops I and III display high levels of sequence conservation 
(Figure 1-11). In light of this observation, the current annotation of H. pylori 
Csd6, as well as its homologs in ε-proteobacteria, as belonging to the 
protein family containing an ‘LD-TPase’ catalytic domain needs to be 
revised. I propose that they should be classified as a third distinct family of 
LD-CPase, as initially noted by others (Cadby and Lovering, 2014). 
Enhanced cell attachment of H. pylori leads to an increased immune 
response of the host (Guruge et al., 1998). Too much attachment may thus 
be detrimental to the bacterium, suggesting a role for motility in the proper 
balance of bacterial levels during infection. This is intriguing, given that H. 
pylori Csd6 is known to be involved in regulating motility through trimming 
of the peptidoglycan-derived peptides as an LD-CPase or through affecting 
the Pse-glycosylation level of flagellin. This study shows that the active-site 
of Csd6 ‘LD-TPase’ domain is tailored to function as the LD-CPase, which 
converts muramyl tetrapeptides into muramyl tripeptides. As Csd6 is 
nonfunctional as LD-TPase, muramyl tripeptides in the peptidoglycan cannot 
be 3→3 cross-linked. This is consistent with the previous reports that the 
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Helicobacter peptidoglycan layer lacks 3→3 cross-links (Costa et al., 1999; 
Sycuro et al., 2010; Lavollay et al., 2008). An in silico docking shows that 
the Csd6 NTF-like domain presents a potential binding site for Pse, 
supporting its role in the control of the glycosylation level of flagellin. 
Relaxation of peptidoglycan 4→3 cross-linking was reported to promote H. 
pylori’s helical shape and stomach colonization (Sycuro et al., 2010). Csd6 
plays a critical role in determining the helical cell shape of H. pylori, 
because it can limit the supply of substrates for peptidoglycan 4→3 cross-
linking. In conclusion, our study on the multi-domain, multi-functional 
Csd6 provides further insights into the strategy of H. pylori for regulating its 




Adams, P. D., Afonine, P. V., Bunkoczi, G., Chen, V. B., Davis, I. W., 
Echols, N., Headd, J. J., Hung, L. W., Kapral, G. J., Grosse-Kunstleve, 
R. W., McCoy, A. J., Moriarty, N. W., Oeffner, R., Read, R. J., 
Richardson, D. C., Richardson, J. S., Terwilliger, T. C., and Zwart, P. H. 
(2010) PHENIX: a comprehensive Python-based system for 
macromolecular structure solution. Acta Crystallogr. sect. D Biol. 
Crystallogr. 66:213–221. 
An, D. R., Kim, H. S., Kim, J., Im, H. N., Yoon, H. J., Yoon, J. Y., Jang, J. 
Y., Hesek, D., Lee, M., Mobashery, S., Kim, S. J., Lee, B. I., and Suh, S. 
W. (2015) Structure of Csd3 from Helicobacter pylori, a cell shape-
determining metallopeptidase. Acta Crystallogr. sect. D Biol. 
Crystallogr. 71:675–686. 
Asakura, H., Churin, Y., Bauer, B., Boettcher, J. P., Bartfeld, S., Hashii, N., 
Kawasaki, N., Mollenkopf, H. J., Jungblut, P. R., Brinkmann, V., and 
Meyer, T. F. (2010) Helicobacter pylori HP0518 affects flagellin 
glycosylation to alter bacterial motility. Mol. Microbiol. 78:1130–1144. 
 72
Berg, H. C., and Turner, L. (1979) Movement of microorganisms in viscous 
environments. Nature 278:349–351. 
Biarrotte-Sorin, S., Hugonnet, J. E., Delfosse, V., Mainardi, J. L., Gutmann, 
L., Arthur, M., and Mayer, C. (2006) Crystal structure of a novel beta-
lactam-insensitive peptidoglycan transpeptidase. J. Mol. Biol. 359:533–
538. 
Bielnicki, J., Devedjiev, Y., Derewenda, U., Dauter, Z., Joachimiak, A., and 
Derewenda, Z. S. (2006) B. subtilis ykuD protein at 2.0 Å resolution: 
insights into the structure and function of a novel, ubiquitous family of 
bacterial enzymes. Proteins 62:144–151. 
Bonis, M., Ecobichon, C., Guadagnini, S., Prevost, M. C., and Boneca, I. G. 
(2010) A M23B family metallopeptidase of Helicobacter pylori 
required for cell shape, pole formation and virulence. Mol. Microbiol. 
78:809–819. 
Cadby, I. T., and Lovering, A. L. (2014) Life in the “old bag” yet: structure 
of peptidoglycan L,D-carboxypeptidases. Structure 22:932–934. 
Chamaillard, M., Hashimoto, M., Horie, Y., Masumoto, J., Qiu, S., Saab, L., 
Ogura, Y., Kawasaki, A., Fukase, K., Kusumoto, S., Valvano, M. A., 
Foster, S. J., Mak, T. W., Nunez, G., and Inohara, N. (2003) An 
 73
essential role for NOD1 in host recognition of bacterial peptidoglycan 
containing diaminopimelic acid. Nature immunol. 4:702–707. 
Chaput, C., Ecobichon, C., Cayet, N., Girardin, S. E., Werts, C., Guadagnini, 
S., Prevost, M. C., Mengin-Lecreulx, D., Labigne, A., and Boneca, I. G. 
(2006) Role of AmiA in the morphological transition of Helicobacter 
pylori and in immune escape. PLoS Pathog. 2:e97 
Chaput, C., Labigne, A., and Boneca, I. G. (2007) Characterization of 
Helicobacter pylori lytic transglycosylases Slt and MltD. J. Bacteriol. 
189:422–429. 
Chen, V. B., Arendall, W. B., 3rd, Headd, J. J., Keedy, D. A., Immormino, 
R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., and Richardson, 
D. C. (2010) MolProbity: all-atom structure validation for 
macromolecular crystallography. Acta Crystallogr. sect. D Biol. 
Crystallogr. 66:12–21. 
Cordillot, M., Dubee, V., Triboulet, S., Dubost, L., Marie, A., Hugonnet, J. 
E., Arthur, M., and Mainardi, J. L. (2013) In vitro cross-linking of 
Mycobacterium tuberculosis peptidoglycan by L,D-transpeptidases and 
inactivation of these enzymes by carbapenems. Antimicrob. Agents 
Chemother. 57:5940–5945. 
 74
Costa, K., Bacher, G., Allmaier, G., Dominguez-Bello, M. G., Engstrand, L., 
Falk, P., de Pedro, M. A., and Garcia-del Portillo, F. (1999) The 
morphological transition of Helicobacter pylori cells from spiral to 
coccoid is preceded by a substantial modification of the cell wall. J. 
Bacteriol. 181:3710–3715. 
Covaleda, G., del Rivero, M. A., Chávez, M. A., Avilés, F. X., and Reverter, 
D. (2012) Crystal structure of novel metallocarboxypeptidase inhibitor 
from marine mollusk Nerita versicolor in complex with human 
carboxypeptidase A4. J. Biol. Chem. 287:9250–9258. 
Das, D., Herve, M., Elsliger, M. A., Kadam, R. U., Grant, J. C., Chiu, H. J., 
Knuth, M. W., Klock, H. E., Miller, M. D., Godzik, A., Lesley, S. A., 
Deacon, A. M., Mengin-Lecreulx, D., and Wilson, I. A. (2013) 
Structure and function of a novel LD-carboxypeptidase a involved in 
peptidoglycan recycling. J. Bacteriol. 195:5555–5566. 
Dodson, G., and Wlodawer, A. (1998) Catalytic triads and their relatives. 
Trends Biochem. Sci. 23:347–352. 
Doerks, T., Bork, P., Kamberov, E., Makarova, O., Muecke, S., and 
Margolis, B. (2000) L27, a novel heterodimerization domain in receptor 
targeting proteins Lin-2 and Lin-7. Trends Biochem. Sci. 25:317–318. 
 75
Emsley, P., Lohkamp, B., Scott, W. G., and Cowtan, K. (2010) Features and 
development of Coot. Acta Crystallogr. sect. D Biol. Crystallogr. 
66:486–501. 
Frirdich, E., Vermeulen, J., Biboy, J., Soares, F., Taveirne, M. E., Johnson, J. 
G., DiRita, V. J., Girardin, S. E., Vollmer, W., and Gaynor, E. C. 
(2014) Peptidoglycan LD-carboxypeptidase Pgp2 influences 
Campylobacter jejuni helical cell shape and pathogenic properties and 
provides the substrate for the DL-carboxypeptidase Pgp1. J. Biol. Chem. 
289:8007–8018. 
Gakhar, L., Malik, Z. A., Allen, C. C., Lipscomb, D. A., Larkin, M. J., and 
Ramaswamy, S. (2005) Structure and increased thermostability of 
Rhodococcus sp. naphthalene 1,2-dioxygenase. J. Bacteriol. 187:7222–
7231. 
Gaskell, A., Crennell, S., and Taylor, G. (1995) The three domains of a 
bacterial sialidase: a beta-propeller, an immunoglobulin module and a 
galactose-binding jelly-roll. Structure 3:1197–1205. 
Girardin, S. E., Boneca, I. G., Carneiro, L. A., Antignac, A., Jehanno, M., 
Viala, J., Tedin, K., Taha, M. K., Labigne, A., Zahringer, U., Coyle, A. 
J., DiStefano, P. S., Bertin, J., Sansonetti, P. J., and Philpott, D. J. 
 76
(2003) Nod1 detects a unique muropeptide from gram-negative 
bacterial peptidoglycan. Science 300:1584–1587. 
Gouet, P., Robert, X., and Courcelle, E. (2003) ESPript/ENDscript: 
Extracting and rendering sequence and 3D information from atomic 
structures of proteins. Nucleic Acids Res. 31:3320–3323. 
Guruge, J. L., Falk, P. G., Lorenz, R. G., Dans, M., Wirth, H. P., Blaser, M. 
J., Berg, D. E., and Gordon, J. I. (1998) Epithelial attachment alters the 
outcome of Helicobacter pylori infection. Proc. Natl. Acad. Sci. U.S.A. 
95:3925–3930. 
Harris, B. Z., Venkatasubrahmanyam, S., and Lim, W. A. (2002) 
Coordinated folding and association of the LIN-2, -7 (L27) domain. An 
obligate heterodimerization involved in assembly of signaling and cell 
polarity complexes. J. Biol. Chem. 277:34902–34908. 
Hazell, S. L., Lee, A., Brady, L., and Hennessy, W. (1986) Campylobacter 
pyloridis and gastritis: association with intercellular spaces and 
adaptation to an environment of mucus as important factors in 
colonization of the gastric epithelium. J. Infect. Dis. 153:658–663. 
Hohlbein, J., Craggs, T. D., and Cordes, T. (2014) Alternating-laser 
excitation: single-molecule FRET and beyond. Chem. Soc. Rev. 
43:1156–1171. 
 77
Holm, L., and Rosenström, P. (2010) Dali server: conservation mapping in 
3D. Nucleic Acids Res. 38:W545–549. 
Hoyland, C. N., Aldridge, C., Cleverley, R. M., Duchene, M. C., Minasov, 
G., Onopriyenko, O., Sidiq, K., Stogios, P. J., Anderson, W. F., Daniel, 
R. A., Savchenko, A., Vollmer, W., and Lewis, R. J. (2014) Structure of 
the LdcB LD-carboxypeptidase reveals the molecular basis of 
peptidoglycan recognition. Structure 22:949–960. 
Josenhans, C., Vossebein, L., Friedrich, S., and Suerbaum, S. (2002) The 
neuA/flmD gene cluster of Helicobacter pylori is involved in flagellar 
biosynthesis and flagellin glycosylation. FEMS Microbiol. Lett. 
210:165–172. 
Kabsch, W., and Sander, C. (1983) Dictionary of protein secondary 
structure: pattern recognition of hydrogen-bonded and geometrical 
features. Biopolymers 22:2577–2637. 
Kim, C., Kim, J. Y., Kim, S. H., Lee, B. I., and Lee, N. K. (2012) Direct 
characterization of protein oligomers and their quaternary structures by 
single-molecule FRET. Chem. Commun. (Camb) 48:1138–1140. 
Kim, H. S., Kim, J., Im, H. N., An, D. R., Lee, M., Hesek, D., Mobashery, 
S., Kim, J. Y., Cho, K., Yoon, H. J., Han, B. W., Lee, B. I., and Suh, S. 
W. (2014) Structural basis for the recognition of muramyltripeptide by 
 78
Helicobacter pylori Csd4, a D,L-carboxypeptidase controlling the 
helical cell shape. Acta Crystallogr. sect. D Biol. Crystallogr. 70:2800–
2812. 
Kim, H. S., Kim, J., Im, H. N., Yoon, J. Y., An, D. R., Yoon, H. J., Kim, J. 
Y., Min, H. K., Kim, S. J., Lee, J. Y., Han, B. W., and Suh, S. W. 
(2013) Structural basis for the inhibition of Mycobacterium tuberculosis 
L,D-transpeptidase by meropenem, a drug effective against extensively 
drug-resistant strains. Acta Crystallogr. sect. D Biol. Crystallogr. 
69:420–431. 
Kim, S. W., Cha, S. S., Cho, H. S., Kim, J. S., Ha, N. C., Cho, M. J., Joo, S., 
Kim, K. K., Choi, K. Y., and Oh, B. H. (1997) High-resolution crystal 
structures of Δ5-3-ketosteroid isomerase with and without a reaction 
intermediate analogue. Biochemistry 36:14030–14036. 
Kim, S., Oh, D. B., Kang, H. A., and Kwon, O. (2011) Features and 
applications of bacterial sialidases. Appl. Microbiol. Biotechnol. 91:1–
15. 
Korza, H. J., and Bochtler, M. (2005) Pseudomonas aeruginosa LD-
carboxypeptidase, a serine peptidase with a Ser-His-Glu triad and a 
nucleophilic elbow. J. Biol. Chem. 280:40802–40812. 
 79
Kostrzynska, M., Betts, J. D., Austin, J. W., and Trust, T. J. (1991) 
Identification, characterization, and spatial localization of two flagellin 
species in Helicobacter pylori flagella. J. Bacteriol. 173:937–946. 
Krissinel, E., and Henrick, K. (2007) Inference of macromolecular 
assemblies from crystalline state. J. Mol. Biol. 372:774–797. 
Kusters, J. G., van Vliet, A. H., and Kuipers, E. J. (2006) Pathogenesis of 
Helicobacter pylori infection. Clin. Microbiol. Rev. 19:449–490. 
Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. 
A., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., Lopez, R., 
Thompson, J. D., Gibson, T. J., and Higgins, D. G. (2007) Clustal W 
and Clustal X version 2.0. Bioinformatics 23:2947–2948. 
Lavollay, M., Arthur, M., Fourgeaud, M., Dubost, L., Marie, A., Veziris, N., 
Blanot, D., Gutmann, L., and Mainardi, J. L. (2008) The peptidoglycan 
of stationary-phase Mycobacterium tuberculosis predominantly 
contains cross-links generated by L,D-transpeptidation. J. Bacteriol. 
190:4360–4366. 
Lee, M., Zhang, W., Hesek, D., Noll, B. C., Boggess, B., and Mobashery, S. 
(2009) Bacterial AmpD at the crossroads of peptidoglycan recycling 
and manifestation of antibiotic resistance. J. Am. Chem. Soc. 
131:8742–8743. 
 80
Lee, N. K., Kapanidis, A. N., Wang, Y., Michalet, X., Mukhopadhyay, J., 
Ebright, R. H., and Weiss, S. (2005) Accurate FRET measurements 
within single diffusing biomolecules using alternating-laser excitation. 
Biophys. J. 88:2939–2953. 
Lertsethtakarn, P., Ottemann, K. M., and Hendrixson, D. R. (2011) Motility 
and chemotaxis in Campylobacter and Helicobacter. Annu. Rev. 
Microbiol. 65:389–410. 
Li, Y., Karnak, D., Demeler, B., Margolis, B., and Lavie, A. (2004) 
Structural basis for L27 domain-mediated assembly of signaling and 
cell polarity complexes. EMBO J. 23:2723–2733. 
Logan, S. M. (2006) Flagellar glycosylation – a new component of the 
motility repertoire? Microbiology 152:1249–1262. 
Mainardi, J. L., Legrand, R., Arthur, M., Schoot, B., van Heijenoort, J., and 
Gutmann, L. (2000) Novel mechanism of beta-lactam resistance due to 
bypass of DD-transpeptidation in Enterococcus faecium. J. Biol. Chem. 
275:16490–16496. 
Malfertheiner, P., Selgrad, M., and Bornschein, J. (2012) Helicobacter 
pylori: clinical management. Curr. Opin. Gastroenterol. 28:608–614. 
 81
McCarter, L., and Silverman, M. (1990) Surface-induced swarmer cell 
differentiation of Vibrio parahaemolyticus. Mol. Microbiol. 4:1057–
1062. 
Medina-Franco, J. L., Mendez-Lucio, O., and Yoo, J. (2014) Rationalization 
of activity cliffs of a sulfonamide inhibitor of DNA methyltransferases 
with induced-fit docking. Int. J. Mol. Sci. 15:3253–3261. 
Meroueh, S. O., Bencze, K. Z., Hesek, D., Lee, M., Fisher, J. F., Stemmler, 
T. L., and Mobashery, S. (2006) Three-dimensional structure of the 
bacterial cell wall peptidoglycan. Proc. Natl. Acad. Sci. U.S.A. 
103:4404–4409. 
Mitchell, A., Chang, H. Y., Daugherty, L., Fraser, M., Hunter, S., Lopez, R., 
McAnulla, C., McMenamin, C., Nuka, G., Pesseat, S., Sangrador-Vegas, 
A., Scheremetjew, M., Rato, C., Yong, S. Y., Bateman, A., Punta, M., 
Attwood, T. K., Sigrist, C. J., Redaschi, N., Rivoire, C., Xenarios, I., 
Kahn, D., Guyot, D., Bork, P., Letunic, I., Gough, J., Oates, M., Haft, 
D., Huang, H., Natale, D. A., Wu, C. H., Orengo, C., Sillitoe, I., Mi, H., 
Thomas, P. D., and Finn, R. D. (2015) The InterPro protein families 
database: the classification resource after 15 years. Nucleic Acids Res. 
43:D213–221. 
 82
Motoyama, T., Nakasako, M., and Yamaguchi, I. (2002) Crystallization of 
scytalone dehydratase F162A mutant in the unligated state and a 
preliminary X-ray diffraction study at 37 K. Acta Crystallogr. sect. D 
Biol. Crystallogr. 58:148–150. 
Murshudov, G. N., Vagin, A. A., and Dodson, E. J. (1997) Refinement of 
macromolecular structures by the maximum-likelihood method. Acta 
Crystallogr. sect. D Biol. Crystallogr. 53:240–255. 
Ottemann, K. M., and Lowenthal, A. C. (2002) Helicobacter pylori uses 
motility for initial colonization and to attain robust infection. Infect. 
Immun. 70:1984–1990. 
Otwinowski, Z., and Minor, W. (1997) Processing of X-ray diffraction data 
collected in oscillation mode. Methods Enzymol. 276:307–326. 
Pei, J., Kim, B. H., and Grishin, N. V. (2008) PROMALS3D: a tool for 
multiple protein sequence and structure alignments. Nucleic Acids Res. 
36:2295–2300. 
Roesler, B. M., Rabelo-Goncalves, E. M., and Zeitune, J. M. (2014) 
Virulence Factors of Helicobacter pylori: A Review. Clin. Med. 
Insights Gastroenterol. 7:9–17. 
Roubaud Baudron, C., Franceschi, F., Salles, N., and Gasbarrini, A. (2013) 
Extragastric diseases and Helicobacter pylori. Helicobacter 18:44–51. 
 83
Sauvage, E., Kerff, F., Terrak, M., Ayala, J. A., and Charlier, P. (2008) The 
penicillin-binding proteins: structure and role in peptidoglycan 
biosynthesis. FEMS Microbiol. Rev. 32:234–258. 
Scheffers, D. J., and Pinho, M. G. (2005) Bacterial cell wall synthesis: new 
insights from localization studies. Microbiol. Mol. Biol. Rev. 69:585–
607. 
Schirm, M., Soo, E. C., Aubry, A. J., Austin, J., Thibault, P., and Logan, S. 
M. (2003) Structural, genetic and functional characterization of the 
flagellin glycosylation process in Helicobacter pylori. Mol. Microbiol. 
48:1579–1592. 
Schreiber, S., Konradt, M., Groll, C., Scheid, P., Hanauer, G., Werling, H. 
O., Josenhans, C., and Suerbaum, S. (2004) The spatial orientation of 
Helicobacter pylori in the gastric mucus. Proc. Natl. Acad. Sci. U.S.A. 
101:5024–5029. 
Silva, J. R., Roitberg, A. E., and Alves, C. N. (2014) Catalytic mechanism 
of L,D-transpeptidase 2 from Mycobacterium tuberculosis described by 
a computational approach: insights for the design of new antibiotics 
drugs. J. Chem. Inf. Model. 54:2402–2410. 
Sycuro, L. K., Pincus, Z., Gutierrez, K. D., Biboy, J., Stern, C. A., Vollmer, 
W., and Salama, N. R. (2010) Peptidoglycan crosslinking relaxation 
 84
promotes Helicobacter pylori's helical shape and stomach colonization. 
Cell 141:822–833. 
Sycuro, L. K., Rule, C. S., Petersen, T. W., Wyckoff, T. J., Sessler, T., 
Nagarkar, D. B., Khalid, F., Pincus, Z., Biboy, J., Vollmer, W., and 
Salama, N. R. (2013) Flow cytometry-based enrichment for cell shape 
mutants identifies multiple genes that influence Helicobacter pylori 
morphology. Mol. Microbiol. 90:869–883. 
Sycuro, L. K., Wyckoff, T. J., Biboy, J., Born, P., Pincus, Z., Vollmer, W., 
and Salama, N. R. (2012) Multiple peptidoglycan modification 
networks modulate Helicobacter pylori’s cell shape, motility, and 
colonization potential. PLoS Pathog. 8:e1002603. 
Terwilliger, T. C. (2003) Automated main-chain model building by template 
matching and iterative fragment extension. Acta Crystallogr. sect. D 
Biol. Crystallogr. 59:38–44. 
Vagin, A., and Teplyakov, A. (2010) Molecular replacement with MOLREP. 
Acta Crystallogr. sect. D Biol. Crystallogr. 66:22–25. 
Vollmer, W., and Bertsche, U. (2008) Murein (peptidoglycan) structure, 
architecture and biosynthesis in Escherichia coli. Biochim. Biophys. 
Acta 1778:1714–1734. 
 85
Vollmer, W., Blanot, D., and de Pedro, M. A. (2008) Peptidoglycan 
structure and architecture. FEMS Microbiol. Rev. 32:149–167. 
Vollmer, W., Joris, B., Charlier, P., and Foster, S. (2008) Bacterial 
peptidoglycan (murein) hydrolases. FEMS Microbiol. Rev. 32, 259–286 
Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., 
Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G., McCoy, A., 
McNicholas, S. J., Murshudov, G. N., Pannu, N. S., Potterton, E. A., 
Powell, H. R., Read, R. J., Vagin, A., and Wilson, K. S. (2011) 
Overview of the CCP4 suite and current developments. Acta 
Crystallogr. sect. D Biol. Crystallogr. 67:235–242. 
Worku, M. L., Sidebotham, R. L., Walker, M. M., Keshavarz, T., and Karim, 
Q. N. (1999) The relationship between Helicobacter pylori motility, 
morphology and phase of growth: implications for gastric colonization 
and pathology. Microbiology 145:2803–2811. 
Wyckoff, T. J., Taylor, J. A., and Salama, N. R. (2012) Beyond growth: 
novel functions for bacterial cell wall hydrolases. Trends Microbiol. 
20:540–547. 
Xu, G., Ryan, C., Kiefel, M. J., Wilson, J. C., and Taylor, G. L. (2009) 
Structural studies on the Pseudomonas aeruginosa sialidase-like 
 86
enzyme PA2794 suggest substrate and mechanistic variations. J. Mol. 
Biol. 386:828–840. 
Yoo, J., Choi, S., and Medina-Franco, J. L. (2013) Molecular modeling 
studies of the novel inhibitors of DNA methyltransferases SGI-1027 
and CBC12: implications for the mechanism of inhibition of DNMTs. 
PLoS One 8:e62152. 
Young, G. M., Schmiel, D. H., and Miller, V. L. (1999) A new pathway for 
the secretion of virulence factors by bacteria: the flagellar export 




Crystal structure of Rv2258c from Mycobacterium 











Mycobacterium tuberculosis is a highly successful intracellular 
pathogen, infecting nearly one-third of the world’s population. It causes 
tuberculosis (TB), claiming the lives of millions of people in the world 
every year. The advent of multidrug-resistant TB cases, the HIV epidemic, 
imperfect diagnostic assays, limited vaccine efficacy, and non-availability of 
new anti-TB drugs pose a global health problem (Lin and Flynn, 2010). 
Therefore, world-wide efforts are being made to develop new anti-TB drugs 
and more effective vaccines to combat TB. As an important step, the 
genome sequence of M. tuberculosis H37Rv strain was reported in 1998 
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(Cole et al., 1998). However, I still have little or limited functional 
information on a significant portion of approximately 4,090 genes in M. 
tuberculosis (Lew et al., 2011). Identifying the molecular and biological 
functions of the proteins that are encoded by the M. tuberculosis genome 
would provide the groundwork for the development of new anti-TB drug 
targets. 
Methyltransferases (MTases) mediate a wide variety of cellular 
processes, such as cell signaling, metabolite synthesis, and gene regulation 
in nearly all living organisms. They comprise a large family of over 300 
members and transfer a methyl group most frequently from S-adenosyl-L-
methionine (SAM) to various acceptor substrates, which include small 
molecules, lipids, proteins, and nucleic acids, yielding a methylated product 
with S-adenosyl-L-homocysteine (SAH) as a by-product. The Rv2258c 
protein from M. tuberculosis H37Rv and its close orthologs in mycobacteria 
are annotated as SAM-dependent methyltransferases and possible 
transcriptional regulatory proteins. To gain structural insights into the 
function of Rv2258c, specifically, to provide a structural basis to decipher 
substrate binding and specificity, I have determined its crystal structure in 
three forms: ligand-unbound Rv2258c, a binary complex with sinefungin 
(SFG), and a binary complex with SAH. A monomer of Rv2258c consists of 
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two domains, which are linked by a long connecting α-helix. The N-
terminal domain is essential for dimerization and the C-terminal domain has 
the Class I MTase fold. The structure of Rv2258c is distinct from eleven 
other mycobacterial SAM-dependent MTases that have been structurally 
characterized but the overall fold of Rv2258c resembles those of small-
molecule O-MTases. Rv2258c forms a homodimer in the crystal, with the 
N-terminal domains facing each other. Size-exclusion chromatography 
confirms that Rv2258c also exists as a homodimer in solution. Our structure 
reveals that the Rv2258c dimer has a large cavity for binding a methyl-
accepting substrate adjacent to the SFG (or SAH) binding site. It also shows 
that dimerization is essential to form such a cavity, as it is contributed not 
only by two domains and the connecting α-helix of one monomer but also 
by an α-helix in the N-terminal domain of the other monomer. Due to high 
variability of the amino acid residues defining the substrate-binding site, 
further experiments are required to establish the methyl-accepting substrate 
and the biological role of Rv2258c. 
 90
2.2. Material and methods 
 
2.2.1. Cloning, expression, and purification 
To obtain well-diffracting crystals, six constructs encompassing 
residues 1–353 (full-length), 1–320, 4–353, 6–353, 9–353, and 28–353 of 
the Rv2258c protein from M. tuberculosis H37Rv were generated. The 
genes encoding these constructs were amplified by PCR using the genomic 
DNA of M. tuberculosis H37Rv as the template and were cloned into the 
expression vector pET-28b(+) (Novagen). The sequences of both the 
forward and reverse primers used in PCR are listed in Table 2-1. The 
resulting recombinant proteins are fused with hexa-histidine containing tags 
at both N- and C-termini (MGSSHHHHHHSSGLVPRGSH and 
LEHHHHHH, respectively). They were overexpressed in Escherichia coli 
Rosetta 2(DE3) cells. The cells were grown at 37C in Luria Broth culture 
medium containing 30 μg ml-1 kanamycin. Protein expression was induced 
by 0.5 mM isopropyl β-D-thiogalactopyranoside and the cells were 
incubated for additional 20 h at 30C. The cells were harvested by 
centrifugation at 5,600 g for 15 min at 4C and subsequently lysed by 
sonication in ice-cold buffer A (20 mM Tris-HCl at pH 7.9, 500 mM sodium 
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chloride, and 50 mM imidazole), which was supplemented with 10% (v/v) 
glycerol and 1 mM phenylmethylsulfonyl fluoride. The crude lysate was 
centrifuged at 36,000 g for 1 h at 4C to discard the cell debris. The 
supernatant was applied to an affinity chromatography column of HiTrap 
Chelating HP (GE Healthcare), which was previously equilibrated with 
buffer A. The column was eluted with buffer B (20 mM Tris-HCl at pH 7.9, 
500 mM sodium chloride, and 500 mM imidazole), with the Rv2258c 
protein being eluted at 120–180 mM imidazole concentration. The eluted 
protein was further purified by gel filtration on a HiLoad 16/60 Superdex 
200 prep-grade column (GE Healthcare), which was previously 
equilibrated with buffer C (20 mM Tris-HCl at pH 7.0 and 200 mM sodium 
chloride). The protein purity was analyzed by SDS-PAGE. Fractions 
containing the recombinant Rv2258c were pooled and concentrated to 17 
mg ml-1 (0.42 mM monomer concentration) for crystallization using an 
Amicon Ultra-15 Centrifugal Filter Unit (Millipore). Four of the above 
constructs, 1–353 (full-length), 4–353, 6–353, and 9–353, were expressed in 
a soluble form in E. coli and were purified for crystallization trials. The 1-





































































































































































































































































































































































































































































































































































































































































































2.2.2. Crystallization and X-ray data collection 
Crystals were grown at 23°C by the sitting drop vapor diffusion method 
using a Mosquito robotic system (TTP Labtech). The 1–353 (full-length) 
and 4–353 constructs produced crystals diffracting poorly to 4 Å only, while 
the 9–353 construct did not yield crystals. Only the 6–353 construct gave 
well-diffracting crystals. To obtain ligand-free crystals of the 6–353 
construct (‘Rv2258c-unbound’), a sitting drop was prepared by mixing 0.2 
μl of the protein solution in buffer C and 0.2 μl of the reservoir solution 
[200 mM sodium malonate at pH 6.0 and 20% (v/v) PEG 3350]. The sitting 
drop was equilibrated against 100 μl of the reservoir solution. Crystals grew 
up to approximate dimensions of 0.2 mm × 0.3 mm × 0.2 mm within a few 




Figure 2-1. Crystals of Rv2258c-unbound from M. tuberculosis 
(A) Crystals with approximate dimensions of 0.05 mm  0.1 mm  0.05 mm 
before optimization. (B) Best crystal with approximate dimensions of 0.2 
mm  0.3 mm  0.2 mm after optimization.  
BA 
 95
In an effort to achieve phasing by single-wavelength anomalous 
diffraction (SAD), the selenomethionine-substituted Rv2258c protein (6–
353 construct) was expressed in E. coli but it did not produce crystals. 
Instead, I prepared a platinum derivative of Rv2258c-unbound crystals by 
soaking them for 90 min in 5 μl of a heavy atom-containing cryoprotectant 
solution, which was prepared by supplementing the reservoir solution with 
30% (v/v) glycerol and 5 mM K2PtCl4. 
Attempts to co-crystallize the ligand-bound Rv2258c protein were not 
successful due to the tendency of the protein to aggregate in the presence of 
the ligands. Therefore, crystals of Rv2258c complexed with either 
sinefungin (SFG), an analog of the co-substrate S-adenosyl-L-methionine 
(SAM), or the by-product S-adenosyl-L-homocysteine (SAH) (‘Rv2258c-
SFG’ and ‘Rv2258c-SAH’, respectively) were obtained by soaking crystals 
of Rv2258c-unbound for 1 min in 5 μl of a cryoprotectant solution, which 
was prepared by supplementing the reservoir solution with 30% (v/v) 
glycerol and 19.9 mM SFG (or 12.5 mM SAH). 
A set of X-ray diffraction data from a ligand-free crystal of Rv2258c 
(‘Rv2258c-unbound’) was collected to 1.83 Å on an Area Detector Systems 
Corporation Q270 CCD detector at the beamline BL-7A of Pohang Light 
Source, Korea. All the raw data were processed and scaled using the 
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program suite HKL2000 (Otwinowski and Minor, 1997). Crystals were 
flash-frozen in a nitrogen gas stream at 100 K. The crystal of Rv2258c-
unbound belongs to the space group C2, with unit cell parameters of a = 
109.1 Å, b = 140.6 Å, c = 97.1 Å, and β = 98.5°. Assuming the presence of 
three monomers of the recombinant Rv2258c in the asymmetric unit, the 
Matthew’s parameter and the solvent content are 3.26 Å3 Da-1 and 62.3%, 
respectively. Data collection statistics are given in Table 2-2. 
Several sets of SAD data were collected at 100 K from different 
platinum-derivatized crystals at a wavelength of 1.0717 Å using the Area 
Detector Systems Corporation Q315r CCD detector at the beamline BL-5A 
of Photon Factory, Japan. Data collection statistics are given in Table 2-2.  
X-ray diffraction data from crystals of Rv2258c-SFG and Rv2258c-
SAH were collected at 100 K using an Area Detector Systems Corporation 
Q270 CCD detector at the beamline BL-7A experimental station of Pohang 
Light Source, Republic of Korea and on an Area Detector Systems 
Corporation Q315r CCD detector at the beamline BL-5A of Photon Factory, 
Japan, respectively. The crystal of the Rv2258c-SFG diffracted to 1.90 Å 
and belongs to the space group C2, with unit cell parameters of a = 108.9 Å, 
b = 140.9 Å, c = 96.6 Å, and β = 98.3°. The crystal of Rv2258c-SAH 
diffracted to 2.90 Å and belongs to the space group C2, with unit cell 
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parameters of a = 109.6 Å, b = 140.5 Å, c = 96.1 Å, and β = 97.9°. Both 
crystals contain three monomers per asymmetric unit, giving a Matthew’s 
parameter and solvent fraction of 3.31 Å3 Da-1 and 62.9% for Rv2258c-SFG, 
and 3.27 Å3 Da-1 and 62.4% for Rv2258c-SAH, respectively. Data 




















































































































































































































































































































































































































































































































































Footnotes to Table 2-2 
a Values in parentheses refer to the highest resolution shell.  
b Friedel pairs were treated as separate observations.  
c Rrim = hkl{N(hkl) / [N(hkl) –1]}1/2 i  Ii(hkl) – <I(hkl)>  / hkli Ii(hkl).  
The redundancy‐independent merging R factor gives the precision of 
individual intensity (Diederichs and Karplus, 1997).  
d Rpim = hkl{1 / [N(hkl) –1]}1/2 i  Ii(hkl) – <I(hkl)>  / hkli Ii(hkl). The 
precision indicating merging R factor describes the precision of the averaged 
intensity (Weiss, 2001). 
e CC1/2 is the correlation coefficient of the mean intensities between two 
random half-sets of data (Diederichs and Karplus, 2013). 
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2.2.3. Structure determination and refinement 
Initially, I tried to solve the structure by molecular replacement using a 
monomer structure of RebM from Lechevalieria aerocolonigenes (PDB: 
3BUS) as a search model. The sequence identity between the residues 59–
177 of RebM and the residues 154–276 of Rv2258c is 33%. There was no 
search model that covered the N-terminal half of Rv2258c. The molecular 
replacement solution gave an interpretable electron density only for the β-
strands of the C-terminal domain. Therefore, I attempted SAD phasing. The 
best set of the platinum derivative data located 21 platinum atoms per 
asymmetric unit but the electron density map calculated using the SAD 
phases was poor and largely uninterpretable. Therefore, I improved the 
phases by combining SAD and molecular replacement phases using the 
program AUTOSOL of the PHENIX software package (Adams et al., 2010). 
When the combined phases were further improved by density modification 
using the program Resolve (Terwilliger, 2003), the electron density map 
became interpretable with an overall figure of merit of 0.70. The initial 
model obtained by autobuilding by Resolve was improved through iterative 
cycles of manual model building with Coot (Emsley et al., 2010) and 
refinement with Refmac5 of the CCP4 program suite (Murshudov et al., 
1997). A total of 5% of the data was randomly set aside as test data for the 
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calculation of Rfree (Brünger, 1992). The model quality was assessed using 
the program MolProbity (Chen et al., 2010). Phasing and model refinement 
statistics are given in Tables 2-2 and 2-3.  
Structures of the two binary complexes were determined by molecular 
replacement with the program Phaser within the PHENIX software package 
(Adams et al., 2010) using the refined model of Rv2258c-unbound as a 
search model. 
 102




PDB code 5F8C 5F8F 5F8E 
Resolution range (Å) 50.0–1.83 50.0–1.90 50.0–2.90 
Rwork / Rfreea (%) 19.1 / 22.6 19.2 / 22.1 20.1 / 27.0 
No. of non-hydrogen atoms / average B-factor (Å2) 
Protein 8,030 / 33.1 8,000 / 37.9 7,933 / 47.2 
Water oxygen  716 / 38.5 697 / 44.1 132 / 26.8 
SFG – 81 / 44.4 – 
SAH – – 52 / 51.9 
Glycerol 24 / 41.0 18 / 43.3 – 
R.m.s. deviations from ideal geometry 
Bond lengths (Å) 0.007 0.009 0.010 
Bond angles () 1.15 1.39 1.44 
R.m.s. Z-scoresb 
Bond lengths 0.438 0.490 0.486 
Bond angles 0.589 0.638 0.657 
Ramachandran plot (%)c 
Favored / Outliers 96.2 / 0.0 95.3 / 0.0 95.6 / 0.1 
Poor rotamers (%)c 0. 49 0.85 0.62 
 
Footnotes to Table 2-3 
a Rwork =  | |Fobs| – |Fcalc| | /  |Fobs|, where Rfree is calculated for a randomly 
chosen 5% of reflections, which were not used for structure refinement and 
Rwork is calculated for the remaining reflections.  
b Values obtained using Refmac.  
c Values obtained using MolProbity. 
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2.2.4. Analytical gel filtration 
The recombinant Rv2258c (6–353 construct) in the ligand-unbound 
state was subjected to analytical gel filtration chromatography on a 
Superdex 200 (10/300 GL) column, eluting with buffer C (20 mM Tris–
HCl at pH 7.0 and 200 mM sodium chloride) at a flow rate of 0.5 ml min-1. 
The standard curve was obtained using molecular-weight markers (Sigma 
MWGF200-1KT). Stokes radii of β-amylase, alcohol dehydrogenase, 
carbonic anhydrase, and cytochrome c were calculated from their crystal 
structures (PDB: 1FA2, 2HCY, 1V9E, and 1HRC, respectively) using the 





2.3.1. Structure determination and comparisons among monomer 
models of Rv2258c 
In this study, I have determined the crystal structures of Rv2258c in 
three forms: (i) Rv2258c-unbound at 1.83 Å, (ii) Rv2258c-SFG at 1.90 Å, 
and (iii) Rv2258c-SAH at 2.90 Å (Table 2-2), using the (6–353) construct of 
Rv2258c from M. tuberculosis H37Rv, which is fused with hexahistidine-
containing tags at both N- and C-termini. Three monomers (chains A‒C) are 
present in each asymmetric unit of these crystals. Nine monomer models of 
Rv2258c in these structures contain all 348 residues of the Rv2258c 
construct (residues 6–353) but some residues of the N-and C-terminal 
hexahistidine-containing tags are disordered (Table 2-4). No ligand electron 
density is found in the active site of Rv2258c-unbound. One molecule of 
SFG is bound to each of chains A‒C in Rv2258c-SFG. In Rv2258c-SAH, 
one molecule of SAH is bound to the active site in each of chains A and B, 
while no ligand is bound to chain C. Rv2258c does not show any significant 
conformational changes upon binding of SFG (or SAH). Therefore, chain A 
of Rv2258c-SFG is used to describe the overall structure, unless stated 
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otherwise. 
When I make structural comparisons between any pair of Rv2258c 
monomer models, the root mean square (r.m.s.) deviations are in the range 
of 0.20‒1.29 Å for 348 equivalent Cα positions over the 36 pairwise 
comparisons. The minimal deviation is observed between chain C of 
Rv2258c-unbound and chain A of Rv2258c-SFG. The maximal deviation is 
between chain A of Rv2258c-unbound and chain B of Rv2258c-SAH. 
Structural variations of Cα atoms larger than 2.0 Å occur within the two 
solvent-exposed loops (residues Gly99‒Pro100 and Glu341‒Val343), which 
do not form the co-substrate-binding pocket, and the solvent-exposed 
regions surrounding SFG (or SAH) [α7 (Phe138‒Ala152), a loop connecting 
β3 and α9 (Cys180‒Arg184), and the α10‒β5 segment (Ser204‒Asp234)]. A 
similar pattern of variations is observed between chains A and B of 
Rv2258c-unbound and between chains A and B of Rv2258c-SFG. Therefore, 
the observed structural variations among the Rv2258c models are not 


































































































































































































































































































































































































































































2.3.2. Overall monomer structure of Rv2258c 
The monomer structure of Rv2258c comprises two distinct domains: (i) 
the N-terminal domain (residues Glu6–Tyr135 and Ser291–Ala308) and (ii) 
the C-terminal MTase domain (residues Ile155–Leu290 and Leu309–
Lys353) (Figure 2-2A), which are linked by a long connecting α-helix (α7, 
residues Pro136–Leu154). The N-terminal domain of Rv2258c consists of 
seven α-helices (α1‒α6 and α12) and two β-strands (β1‒β2). α12 is inserted 
between β7 and α13 of the C-terminal domain. The connecting α7 helix 
between the N-terminal and C-terminal domains participates in the 
formation of a putative binding site for a methyl-accepting substrate. The C-
terminal domain of Rv2258c displays a typical Class I MTase fold. It is 
made up of a central seven-stranded β-sheet (β8↑-β9↓-β7↑-β6↑-β3↑-β4↑-
β5↑) that is flanked by five α-helices (α8‒α11 and α13) on both sides of the 
sheet (Figure 2-2B). Among different Classes of SAM-dependent MTases, a 
vast majority of known MTases belong to Class I, which has the Rossmann-





Figure 2-2. Monomer structure and topology diagram of Rv2258c 
(A) Ribbon diagram of Rv2258c-SFG monomer (chain A). The secondary 
structure elements have been defined by the STRIDE program (Heinig and 
Frishman, 2004). The monomer is colored by structural domains: N-
terminal domain (residues 6‒135 and 291‒308) in blue and C-terminal 
domain (residues 155‒290 and 309‒353) in green. The connecting α-helix 7 
(residues 136‒154) is colored in yellow. The bound SFG is shown in ball-
and-stick representation and colored according to atom types (carbon, black; 
nitrogen, blue; and oxygen, red). (B) Topology diagram of the Rv2258c 
monomer fold, with α-helices and β-strands denoted by circles and triangles, 
BA 
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respectively. Secondary structures of the N-terminal domain, the connecting 
α-helix 7, and the Class I MTase fold are colored in blue, yellow, and green, 
respectively. Residue numbers are given for the secondary structure 
elements. 
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2.3.3. Rv2258c exists as a homodimer 
Two chains A and B in the asymmetric unit of Rv2258c-unbound, 
Rv2258c-SFG, and Rv2258c-SAH are related by a non-crystallographic 
two-fold symmetry and they form an intertwined dimer around their N-
terminal domains (Figure 2-3A) in a head-to-head fashion. Chain C and a 
neighboring chain in the other asymmetric unit (designated as C’), which 
are related to each other by a crystallographic two-fold symmetry, form a 
crystallographic dimer. These two kinds of dimer are structurally highly 
similar to each other with an r.m.s. deviation of 0.83 Å for 696 equivalent 
Cα positions. The buried surface area at the interface between chains A and 
B are 3730, 3750, and 3710 Å2 per monomer for Rv2258c-unbound, 
Rv2258c-SFG, and Rv2258c-SAH, respectively, as calculated by the PISA 
server (Krissinel and Henrick, 2007). The interface encompasses about 20% 
of the monomer surface area. Approximately 60% of these interface areas is 
contributed by the N-terminal domain. The extensive dimer interface is 
primarily composed of hydrophobic interactions involving alanine, 
isoleucine, leucine, phenylalanine, and valine (Figure 2-3B). The Stokes 
radius of the ligand-free Rv2258c in solution was estimated to be 3.93 nm 
by performing gel filtration experiments (Figure 2-3C). It agrees well with 
the calculated Stokes radii: 3.68 nm for the dimer between chains A and B 
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of Rv2258c-unbound or 3.70 nm for the dimer between chains C and C’ of 
Rv2258c-unbound. This result supports that Rv2258c exists as a homodimer 
in solution. In the dimeric structure of Rv2258c, the putative methyl-
accepting substrate-binding pocket is contributed by both monomers 
(helices α6‒α7 and α12 of one chain; helix α1 of the other chain). Therefore, 
the observed dimerization of Rv2258c is essential for determining the 










(A) Ribbon diagram of an Rv2258c-SAH homodimer in two different 
orientations. Chains A and B are in deep teal and dark salmon, respectively, 
and the bound SAH molecules are shown as stick models. (B) Electrostatic 
potential surface diagram of chain B in the Rv2258c-SAH homodimer is 
colored in blue and red according to positive and negative potentials, 
respectively. Residues of chain A interacting with the other monomer (chain 
B) are shown as sticks. To show the detailed interactions more clearly, this 
view has a slightly different orientation from the right panel of (A). (C) Plot 
of the calculated Stokes radii (RH) against the retention volumes in size 
exclusion chromatography. Filled sky blue circles are molecular-weight 
markers: β-amylase, 200 kDa; alcohol dehydrogenase, 150 kDa; carbonic 
anhydrase, 29 kDa; cytochrome C, 12 kDa. The red filled circle is Rv2258c. 
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2.3.4. Structural similarity search 
A DALI structural similarity search (Holm and Rosenström, 2010) with 
a monomer model of Rv2258c-unbound (chain A, residues 6-353) indicates 
that the overall fold of Rv2258c closely resembles those of Class I, small-
molecule O-, N-, or C-MTases (Table 2-5; Figure 2-4). MTases displaying 
the highest Z-scores include: (i) caffeic acid O-MTase from Lolium perenne 
(LpOMT1; PDB: 3P9K, chain D; an r.m.s. deviation of 3.2 Å for 312 
equivalent Cα positions, a Z-score of 25.3, and a sequence identity of 19%), 
(ii) mitomycin 7-O-MTase from Streptomyces lavendulae (MmcR; PDB: 
3GXO, chain A; an r.m.s. deviation of 3.6 Å for 319 equivalent Cα positions, 
a Z-score of 25.5, and a sequence identity of 17%), (iii) carminomycin 4-O-
MTase from Streptomyces peucetius (DnrK; PDB: 1TW3, chain B; an r.m.s. 
deviation of 3.6 Å for 317 equivalent Cα positions, a Z-score of 25.0, and a 
sequence identity of 15%), and (iv) human N-acetyl serotonin MTase 
(ASMT; PDB: 4A6E, chain A; an r.m.s. deviation of 3.9 Å for 316 
equivalent Cα positions, a Z-score of 24.9, and a sequence identity of 15%). 
Similar results are obtained when I make a DALI structural similarity search 
with the dimer model of Rv2258c. As in Rv2258c, these MTases consist of 
a C-terminal SAM-dependent MTase domain and an N-terminal domain, 
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which is indispensable for the formation of an intertwined dimer and the 
cavity for binding the substrates. 
The above structural homologs of Rv2258c are involved in the 
biosynthesis of various metabolites such as lignin, mitomycin, daunorubicin, 
and melatonin. Lignin is a heterogeneous polymeric macromolecule and a 
major component of the cell wall in vascular plants. It provides a 
mechanical support for plant tissues and protects the plant from pathogen 
invasion (Louie et al., 2010). Mitomycin is a quinone-containing antibiotic 
isolated from S. caespitosus or S. lavendulae and is used in antitumor 
chemotherapy (Singh et al., 2011). Daunorubicin isolated from S. peucetius 
is also used in the chemotherapy of some cancers (Jansson et al., 2004). 
Melatonin is a multi-tasking molecule found in animals, plants, fungi and 
bacteria, and is involved in various physiological functions such as sleep 
induction and circadian rhythm regulation (Botros et al., 2013). Interestingly, 
many substrates of these structurally similar MTases contain aromatic rings. 
It is plausible that the natural substrate of Rv2258c might be a small 
molecule with aromatic rings. However, the primary substrate of Rv2258c 
cannot be inferred from the structural similarity alone, as the sequence 
motifs involved in binding the methyl-accepting substrate are not highly 












































































































































































































































































































































Figure 2-4. Sequence alignment of Rv2258c with its close structural 
homologs 
Sequence alignment of Rv2258c (SWISS-PROT accession code: O53532) 
and structurally similar MTases: LpOMT1 (caffeic acid O-MTase; SWISS-
PROT accession code: Q9ZTU2), MmcR (mitomycin 7-O-MTase; SWISS-
PROT accession code: Q9X5T6), DnrK (carminomycin 4-O-MTase; 
SWISS-PROT accession code: Q06528), and ASMT (human N-acetyl 
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serotonin MTase; SWISS-PROT accession code: P46597). Every tenth 
residue is marked with a black dot above the sequence of Rv2258c. The 
secondary structures of Rv2258c are colored in blue. Strictly conserved 
residues are highlighted with a red background. Semi-conserved residues 
are highlighted with a yellow background. Conserved sequence motifs 
(Motifs I‒III) and the inserted region are boxed. Sequences were aligned 
using the program ClustalX (Larkin et al., 2007) and the figure was 
generated with the program ESPript (Robert and Gouet, 2014). 
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2.3.5. MTase sequence motifs and SFG (or SAH) binding 
Up to six sequence motifs (I‒VI) are used to identify MTases (Kozbial 
and Mushegian, 2005; Liscombe et al., 2012; Martin and McMillan, 2002). 
One or more residues in “GxGxG” motif at the end of the first β-strand of 
the Class I MTase core fold, the highly-conserved Motif I, bind the adenosyl 
part of SAM. Another strongly conserved acidic residue in Motif II at the 
end of the second β-strand forms hydrogen bonds with the ribose part of 
SAM. Motif III spans the third β-strand, followed by Motif IV spanning the 
fourth strand and the adjoining loops. Both Motifs III and IV include a 
partially-conserved acidic residue, and interact with the adenosyl part and 
the sulfonium part of SAM, respectively. In some Class I MTases, 
hydrophobic residues located on a helix between the fourth and fifth β-
strands (Motif V) make hydrophobic interactions with the adenosyl part of 
SAM (Kozbial and Mushegian, 2005; Liscombe et al., 2012; Martin and 
McMillan, 2002). 
As in other MTase-SAM complexes, Rv2258c interacts with SFG (or 
SAH) in an extended conformation maintained by a network of hydrogen 
bonds and stacking interactions. The SFG (or SAH) binding site of Rv2258c 
is formed by the four loops: β3‒α9, β4‒α10, β5‒β6, and β6‒α11 loops. 
Motifs I, II, and III are conserved in Rv2258c and are responsible for the 
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interaction with SFG (or SAH). The main chain atoms of Gly179 and 
Gly181 of the GxGxG motif (residues 179‒183; Motif I), the most 
important SAM-binding motif, are located in the β3‒α9 loop and are 
hydrogen-bonded to the carboxylate moiety of SFG (or SAH) (Figure 2-5, A 
and B). The carboxylate moiety of SFG (or SAH) makes additional 
hydrogen bonds with the side chain of Ser146 and the main chain of Phe245. 
Motif II of Rv2258c is a conserved acidic residue Asp202, which lies at the 
C-terminus of the β-strand β4. It forms hydrogen bonds with the ribosyl 
moiety of SFG (or SAH) (Figure 2-5, A and B). The main chain atoms of 
Phe203 and Leu230 and the side chain of Gln251 make hydrogen bonds 
with the adenine ring of SFG (or SAH) as well as the side chain of Asp229 
(Motif III). The side chain of Phe203 forms a stacking interaction with the 
adenine ring. Tyr132 (side chain), Phe150 (side chain), and His228 (main 
chain) interact with the ribosyl moiety, the carboxylate moiety, and the 





Figure 2-5. Interactions of SFG (or SAH) with Rv2258c 
Stereo views of the active site region in Rv2258c-SFG (A) and Rv2258c-
SAH (B), with SFG and SAH in black. Most of the interacting residues 
belong to the C-terminal MTase domain in chain A, except Ser146 from the 
connecting α-helix 7 of the same chain. The omit mFo–DFc maps for bound 
ligands in Rv2258c-SFG (A) or Rv2258c-SAH (B) are shown in blue white 
colored mesh contoured at a level of 2.5σ. Hydrogen bonds are indicated by 




interacting residues are shown. Tyr132 (side chain), Phe150 (side chain), 
and His228 (main chain) are in close proximity to SFG (or SAH) but are not 
shown, because they block the view of SFG (or SAH). 
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2.3.6. Rv2258c is a unique SAM-dependent MTase in mycobacteria 
Until now, three-dimensional structures of eleven mycobacterial SAM-
dependent MTases have been determined. They fall into different functional 
groups: (i) lipid MTases [Rv0470c (PDB: 1L1E; Huang et al., 2002), 
Rv0503c (PDB: 1KPI; Huang et al., 2002), Rv0642c (PDB: 2FK8; Boissier 
et al., 2006), Rv0644c (PDB: 1TPY), Rv3392c (PDB:1KP9; Huang et al., 
2002)], (ii) nucleic acid MTases [Rv2118c (PDB: 1I9G; Gupta et al., 2001), 
Rv2372c (PDB: 4L69; Kumar et al., 2014), Rv2966c (PDB:  3P9N; Sharma 
et al., 2015), and MAB_3226c (PDB: 3QUV)], (iii) a small-molecule 
MTase [M. smegmatis EgtD (MSMEG_6247; PDB: 4UY6; Jeong et al., 
2014)], and (iv) a MTase of unknown substrate [M. leprae ML2640c (PDB: 
2UYO; Graña et al., 2007)]. Whereas Rv2372c and MAB_3226c are Class 
IV MTases, the remainders are Class I MTases. Class I and Class IV 
MTases have unrelated folds. Therefore, Rv2258c seems to be distinct from 
these structurally-characterized SAM-dependent MTases in mycobacteria. 
As mentioned above, the overall monomer fold of Rv2258c closely 
resembles those of small-molecule O-, N-, or C-MTases of Class I. 
Therefore, I make some detailed comparisons between Rv2258c and M. 
smegmatis EgtD, which trimethylates the nitrogen atom of histidine to form 
hercynine in ergothioneine biosynthesis. Ergothioneine is an antioxidant 
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secreted by mycobacteria presumably for protection from oxidative stresses 
(Jeong et al., 2014). Although catalytic domains of both Rv2258c and EgtD 
share the Class I MTase fold, they exhibit significantly different structural 
features (Figure 2-6). The N-terminal domain of Rv2258c (α1‒α6 and 
β1‒β2; residues 1‒135) is much larger than that of EgtD (α1‒α2; residues 
11‒55). In contrast, the insertion of Rv2258c [helix α12 (residues 291‒308) 
between β7 and α13] is much smaller than that of EgtD (α8‒α9 and β7‒β11 
between β6 and α10; residues 2‒41 and 198‒286). Furthermore, Rv2258c 
and EgtD differ in their oligomeric states. I have shown that Rv2258c exists 




Figure 2-6. Comparison of monomer structures of Rv2258c-SFG and M. 
smegmatis EgtD 
Ribbon diagram of an Rv2258c-SFG monomer (chain A) is colored as 
follows: the N-terminal domain (residues 6‒154) and the MTase domain 
(residues 155‒276 and 320‒353) are colored in grey and yellow, 
respectively. The inserted region (residues 277‒319) in MTase domain of 
Rv2258c is colored in purple. Ribbon diagram of an M. smegmatis EgtD 
monomer (chain A; PDB code 4UY6) is colored as in the Rv2258c-SFG 
monomer: the N-terminal addition (residues 11‒55), the MTase domain 
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(residues 2‒10, 56‒197, and 287‒321), and the inserted region in MTase 
domain (residues 198‒286). 
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2.3.7. Relatively large substrate-binding cavity of Rv2258c and 
functional implications 
Rv2258c functions as a homodimer, which possesses two large cavities of 
approximately equal volume. The cavity volume in the dimer models of 
ligand-free Rv2258c, i.e., dimers between chains A and B of Rv2258c-
unbound, between chains C and C’ of Rv2258c-unbound, and chains C and 
C’ of Rv2258c-SAH, ranges between 1,560 and 1,860 Å3 with an average of 
1,770 Å3, as calculated by the KVFinder program (Oliveira et al., 2014). 
The cavity volume for ligand-bound Rv2258c dimers between chains A and 
B of Rv2258c-SFG, between chains C and C’ of Rv2258c-SFG, and 
between chains A and B of Rv2258c-SAH, ranges between 530 and 740 Å3 
with an average of 680 Å3, which is available for binding the methyl-
accepting substrate. The inside of this cavity for the methyl-accepting 
substrate in Rv2258c is lined with mainly hydrophobic residues largely 
from one monomer such as proline, leucine, valine, isoleucine, 
phenylalanine, and methionine. Val16 in helix α1 from another monomer of 
the dimer also contributes to this cavity surface. The cavity volumes for 
binding both donor- and acceptor-substrates are 730 Å3 for LpOMT1, 900 
Å3 for MmcR, 1260 Å3 for DnrK, and 850 Å3 for ASMT, respectively. The 
cavity volumes for binding a methyl-accepting substrate are 360 Å3 for 
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LpOMT1, 560 Å3 for MmcR, 910 Å3 for DnrK, and 420 Å3 for ASMT, 
respectively (Fig. 4), which correlate well with the molecular volume of 
their methyl-accepting substrates (220, 410, 700, and 270 Å3 for 
coniferaldehyde bound to LpOMT1, mitomycin A in MmcR, 4-methoxy-ε-
rhodomycin T in DnrK, and N-acetylserotonin in ASMT, respectively). 
Except DnrK, the structural homologs of Rv2258c have smaller cavity 
volumes for binding a methyl-accepting substrate. Most of these substrates 
fall into aromatic ring-containing compounds (Figure 2-7). If Rv2258c 
functions as a small-molecule MTase, I could infer that a natural substrate 





Figure 2-7. Comparison of homodimeric structures of Rv2258c and its 
close structural homologs 
Comparison of dimeric structures of Rv2258c-SFG, LpOMT1, MmcR, 
DnrK, and ASMT (lower panel). A methyl donor (or its analog) and a 
methyl-accepting substrate (when present) are shown in sticks, together with 
the cavity for binding a methyl-accepting substrate (upper panel). Ribbon 
diagrams of the dimeric structure are colored as follows: Rv2258c-SFG 
(chain C in chocolate and chain C’ in salmon), LpOMT1 (chain A in forest 
and chain B in limon), MmcR (chain A in deep purple and chain B in light 
pink), DnrK (chain A in deep teal and chain B in pale cyan), and ASMT 
(chain A in deep blue and chain A’ in light blue) (bottom panel). The 
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cavities are shown as mesh and are colored in lighter color of the two 
monomers, respectively. The depicted cavities correspond to the volume for 
binding the methyl-accepting substrates. The cavities are calculated by the 
KVFinder program (Oliveira et al. 2014) using the default values of step 
size (0.6 Å), probe in size (1.4 Å), and probe out size (4.0 Å). 
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Another potential clue to the function of Rv2258c may be the location 
(2,530,836 – 2,531,897 bp) of its gene in the genome of M. tuberculosis 
H37Rv. Interestingly, Rv2257c, the gene encoding a potential β-lactamase, 
is located adjacent to the Rv2258c with only a 14-bp interval (at 2,530,004 – 
2,530,822 bp). Indeed, these two genes are predicted to lie within the same 
operon by the ProOpDB site (http://operons.ibt.unam.mx/OperonPredictor/) 
(Taboada et al., 2012) and the TB database site 
(http://www.broadinstitute.org/annotation/genome/tbdb/) (Galagan et al., 
2010). Mb2281c from M. bovis is identical in its amino acid sequence to 
that of Rv2257c and the crystal structure of Mb2281c (PDB: 3I7J, 
unpublished deposition) confirms that it has a β-lactamase fold. 
Additionally, the subcellular location prediction servers, including CELLO 
(Yu et al., 2006), SubLoc (Hua and Sun, 2001), and PSORTb (Yu et al., 
2010), indicate that Rv2258c may exist in the cytoplasm of mycobacteria. 
Taken together, it seems that Rv2258c may be expressed together with the 
putative β-lactamase Rv2257c and it may methylate unknown small 
molecules in the cytoplasm, when M. tuberculosis is subject to harsh 
environments like the presence of antibiotics. One conceivable scenario is 
that Rv2258c might be involved in conferring drug resistance to M. 
tuberculosis. The present structural work provides useful, although limited, 
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insights into the function of Rv2258c, while further studies are required to 
establish its precise biological role. 
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2.4. Conclusions  
 
To date, over 300 members of the MTase family (EC 2.1.1.-) have been 
classified on the basis of their substrate specificity (small molecule, lipid, 
protein, DNA, and RNA) and on the atom type  targeted for methylation 
(oxygen, carbon, nitrogen, sulfur) (Liscombe et al., 2012). In addition, most 
of them are divided into five Classes (Classes I‒V) based on the overall fold 
of their catalytic domain (Schubert et al., 2003). In this study, I have 
determined the crystal structure of Rv2258c, a SAM-dependent MTase in M. 
tuberculosis. I have found that Rv2258c exists as a homodimer both in the 
crystal and in the solution, indicating that Rv2258c functions as a dimer. 
Rv2258c is structurally similar to small-molecule O-MTases with nonpolar 
substrates with aromatic rings. However, further experiments are required to 
establish the natural substrate and the biological role of Rv2258c, because 
small-molecule MTases do not possess widely conserved structural 
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Structural Studies of Csd6 Protein from Helicobacter pylori 
and Rv2258c Protein from Mycobacterium tuberculosis 
 
헬리코박터 파일로리균 Csd6 와 결핵균 Rv2258c 단백질의 구조 연구 
 
헬리코박터 파일로리균은 위암을 비롯한 위장관 질병을 일으킨다. 
결핵균은 결핵을 일으키는데, 전 세계적으로 매년 수백만 명의 목숨을 
앗아가고 있다. 약제 내성을 갖는 병원성 박테리아의 증가는 세계적으로 
심각한 문제이다. 따라서 새로운 항미생물제의 발견이 시급하다. 병원성 
박테리아 단백질의 분자적, 생물학적 기능을 밝히는 것은 새로운 
항미생물제 개발에 초석을 제공한다. 본 연구에서는 헬리코박터 
파일로리균 Csd6 단백질과 결핵균 Rv2258c 단백질의 삼차원 구조를 
규명하였다. 
헬리코박터 파일로리균 Csd6 단백질은 펩티도글리칸 펩타이드를 
자름으로써 나선형의 세포 모양 결정하는데 중요한 역할을 한다. Csd6 는 
또한 flagellar FlaA 단백질의 탈당화 반응에 관여한다고 알려져 있다. 
Csd6 의 구조는 Csd6 의 가운데에 위치한 활성 도메인이 L,D-
transpeptidases 와 유사하나 그 활성 부위의 형태가 지금까지 알려진 L,D-
transpeptidases 과는 다른 특이성을 갖는다는 것을 보였다. 질량 분석도 
Csd6 가 L,D-transpeptidase 가 아닌 단지 L,D-carboxypeptidase 로서 
기능한다는 것을 확인했다. D-Ala 가 결합된 구조를 통해 활성 부위에 
기질과 생성물의 결합 모드를 보였다. 구조-기능 분석을 기반으로 하여, 
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Csd6 와 Csd6 유사단백질들이 새로운 L,D-carboxypeptidase 로 
분류되어야 한다고 제안했다. 
결핵균 Rv2258c 단백질은 S-adenosyl-L-methionine-dependent 
methyltransferase (MTase)로 예상되었다. MTase 는 거의 모든 
생물들의 세포 신호, 대사물질 합성, 유전자 조절 등과 같은 다양한 세포 
과정에 관여하고 있다. Rv2258c 의 구조는 Rv2258c 단량체가 두 개의 
도메인이 하나의 긴 α -helix 에 의해 연결되어 있음을 보였다. 
Rv2258c 의 아미노 말단 도메인은 이량체를 이루는데 필요하며 
카르복실기 말단 활성 도메인은 Class I 의 MTase fold 를 가지고 있다. 
결합된 sinefungin (or S-adenosyl-L-homocysteine)과의 상호작용뿐만 
아니라 Rv2258c 의 전체 fold 는 small-molecule MTases 과 유사하다. 
Rv2258c 는 메틸기를 받는 기질이 결합할 수 있는 상대적으로 큰 소수성의 
공간을 가지고 있으며, 이를 통해 부피가 크고 극성이 없는 분자가 
결핵균의 Rv2258c 에 의해 메틸화될 것임을 제시하였다. 
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flagellin / peptidoglycan / cell motility / protein structure / structure-function / 
Rv2258c / Mycobacterium tuberculosis / small-molecule methyltransferase / 
sinefungin / S-adenosyl-L-homocysteine 
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